Entries refer to abstract numbers. Click on the number to view abstract.
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
A549 lung cancer cells, PHEX expression P65
Achilles tendon healing P28, P142
achondroplasia OR53
acid, metabolically produced, bone resorption and P524
acid-base balance, role of skeleton SC17
acidosis, chronic metabolic P184
actin, alpha-smooth muscle, in fibrous dysplasia P108
Addison's disease, bone mass changes P69
adenylate cyclase, PTH and retinoic acid interaction P189
adherence see compliance
adipocytes
differentiation
inhibition by estrogen OR36
troglitazone and P20
gene expression, TGF-beta2 and SC34
adolescents
pregnant, Ca supplementation P436
adrenomedullin, in osteoblast-like cells P202
adrenomedullin receptors, in osteoblast-like cells P202
adult T-cell lymphoma (ATL) P54
age
apoptosis in growth plate and P29
BMC distribution in lumbar spine and P441
bone mass of whole bones and P440
fracture healing and VEGF expression P177
fracture risk and SC25
at menarche, BMD and P391
menopausal, lumbar versus femoral BMD P307
spinal cancellous microarchitecture and P341
spine and iliac crest histomorphometry and P340
VDR expression and P649
aggressive behavior, in eNOS and nNOS knockout mice P194
aging
animal model of frailty OR17
bone turnover markers and P505
factors predicting fractures and OR16
osteoprotegerin and P170
PMCA, sodium-calcium exchanger and PTHrP receptor and SY9
see also elderly
Akt, in eNOS activation P231
ALCAM see CD166
alcohol
abuse, osteoporosis and P465
intake, bone loss and SC24
alendronate
1,25(OH)2D3 inhibition of PTHrP and P250
esophageal transit of tablets P551
in glucocorticoid-induced osteoporosis P573
in male osteoporosis P557
in osteogenesis imperfecta P63, P556
in osteopenia, vertebral fracture prevention P575
in osteoporosis
BMD changes after discontinuation P550
ER-beta RsaI polymorphism and P561
fracture risk reduction IN9, P576
nonvertebral fracture risk reduction P565
in pediatric patients P609
side effects and discontinuation OR28
in ovariectomized rats P520
plus enzyme therapy P555
in postmenopausal osteoporosis SC19, SC21, P554
after successful cyclical etidronate P549
biochemical resorption markers P614
in Chinese women with vertebral fractures P566
gastric ulcer rates P546
and impaired fasting glucose P541
rechallenge after discontinuation SC21
risedronate after discontinuation P569
versus risedronate P546
in primary biliary cirrhosis P543
alfacalcidol
bone turnover markers and P613
induction of hypercalcemia P632
nonvertebral fracture risk reduction P565
in osteoporosis prevention P637
in ovariectomized rats P520, P633, P636
and phenytoin, vitamin K analogs and P450
in rheumatoid arthritis P639
versus vitamin D P636
versus vitamin K2 P633
and zonisamide, bone vitamin K levels and P634
algo-dystrophy, foot P67
alkaline-forming foods, bone health and SC17
alkaline phosphatase
bone (BAP), assay methods compared P347
multiple new substrates P111
periosteal, in femoral neck P212
alpha-alumina particles, IL-6 expression and P171
aluminium
and fluoride intoxication P91
PTH synthesis inhibition P192
amylin
inhibition of osteopenia in diabetic rats P495
protein kinase C activation P144
receptors, novel OR44
analgesic effects
calcitonin in osteoporotic back pain P631
ibandronate in metastatic bone pain P168
zoledronic acid P553
androgen, receptor genotypes, and BMD in men P127
androgens
ablation therapy for prostate cancer P121
actions on trabecular bone OR38
membrane action in osteoblasts SC41
in men with vertebral fractures P513
suppression of osteoclast formation SC3
angiogenesis, in fibrous dysplasia P108
angiotensin converting enzyme (ACE) inhibitors P518, P531
ankle fractures, BMD and ultrasound properties P426
ankylosing spondylitis
BMD at distal forearm P83
versus ochronosis P97
vertebral deformities P82
vitamin D status P503
anorexia nervosa
fractures OR18
vertebral BMD and bone turnover P382
anthropometry, radius fractures and P381
anticonvulsant (antiepileptic) agents P437, P634, P638
antiestrogens, molecular pharmacology IN11
antihypertensive therapy, BMD and P531
antiresorptive therapy
3D simulation model P616
osteoporotic fracture prevention IN9
see also bisphosphonates
antiretroviral therapy SC32, P502
antler
old, effects on bone marrow stromal stem cells P239
retinoic acid receptors OR60
AP-1
in mechanical stress-induced bone formation OR62
signaling, mechanical environment and SC43
apatite formation
dentin phosphophoryn and P7
in poly(vinylalcohol) gel P529
APO2L/TRAIL-induced apoptosis OR50, P160
apolipoprotein E genotype, in postmenopausal women P139
apoptosis
1alpha,25(OH)2D3-induced SC35
chemotherapy-induced sensitization OR50
growth plate P29
osteoblast IN7
microgravity and P223
sodium fluoride and P197
osteoclast SC5
bisphosphonate-induced P290
clodronate-mediated P291
aromatase
mutations P512
over-expressing mice P474
b-arrestin2 OR75
arterial calcification, in high cholesterol fed rabbits P5
arthritis
osteoporosis risk in severe P366
type 2 collagen-induced, incadronate therapy P24
see also osteoarthritis; rheumatoid arthritis
arthroplasty, elective, osteoporosis risk P366
aseptic loosening, implants P33
Asians
osteoporosis risk assessment P319
vitamin D deficiency P467, P469, P470, P582
asthma
and fracture risk in perimenopausal women P409
QUS parameters in childhood P453
steroid-treated, effects on bone P454, P457
AT1 receptor antagonist, skeletal effects P518
atherosclerotic lesions, OPG and OPGL P80
athletes
calcaneal ultrasonometry P481
female, bone density P486
ATP
clodronate metabolism and P292
ODF (RANKL) expression and P274
atremate brachiopod shells P6
atrial natriuretic peptide (ANP), osteoblast differentiation and P229
avians
Ca and calciotropic hormones SY5
ER-alpha and ER-beta mRNAs SY8
genes in eggshell calcification SY7
osteoporosis SY6
PTH polyhormone actions on oviduct motility SY13
back extensor strengthening exercises, in osteoporosis P603
back pain
before and after vertebral fractures P394
calcitonin for osteoporotic P631
kyphoplasty for vertebral fractures and P532
in ochronosis P97
balance, and BMD in elderly women P424
Balb/c mouse P62
benzo[a]pyrene, in estrogen replete ovariectomized rats P528
beta-crosslaps, serum, subcutaneous estradiol implant and P597
BHK21 cells, calcitonin receptor-GFP constructs P281
biglycan-fibromodulin double knockout mice OR54
bioluminescent reporter imaging, metastatic cells P152
biomaterials see implant materials
biomechanical properties
in eSS diabetic rats P89
HRT in rats and mice and P447
hypobaria and P40
see also bone strength
birds see avians
bisphosphonates
3D simulation model P616
FPP synthase and IPP isomerase inhibition SC1
mechanism of irritation SC22
in melorheostosis P105
osteoclast apoptosis induction P290
in postmenopausal osteoporosis P552
protein kinase C and P293
receptor, evidence for P252
retention in Paget's disease P118
upper GI lesions, evidence for P564
see also specific agents
blood pressure, and fracture risk in men P475
BMC see bone mineral content
BMD see bone mineral density
BMP see bone morphogenetic protein
body composition
accuracy of DXA estimation P321
assessment in clinical practice P325
in mucopolysaccharidosis type IV P104
body mass index (BMI)
low, vertebral BMD and bone turnover and P382
lumbar versus femoral BMD P307
bone allografts
effects on osteoblast P238
mechanism of failure P23
bone cyst, unicameral (simple) P100
bone densitometry
between-machine differences P338
fracture history and P331
frequency in peri- and postmenopausal women P302
osteoporosis risk factor assessment and P620
in primary care P330
sex-bias in referrals P612
socioeconomic deprivation and referral P303
see also dual energy X ray absorptiometry
bone development at puberty, gender differences P21
bone formation
BMP4 transduced muscle-derived stem cells OR21
BMP-6 expressing cells OR26
BMP-7 and P53
in brittle mouse model P66
canine prostate tissue and P120
cystein-rich protein 61 and P203
demonstration in vivo P257
distraction-associated see distraction osteogenesis
electromagnetic field stimulation and P241
estrogen related receptor (ERRa) and OR71
IGF-II supplemented hydroxyapatite P173
in mechanically unloaded p53 knockout mice P480
mechanical stress and OR62
in metastatic bone cancer IN12
milk basic protein and P538
in multiple myeloma P150
negative regulation by vitamin D OR40
nicotine and P233
in novel porous hydroxyapatite P235
osteoblast apoptosis and IN7
osteoblastic control IN6
proteasome inhibitor actions OR19
in stromal defects of bone marrow P110
troglitazone and P20
see also ossification
bone Gla protein see osteocalcin
bone growth
alendronate in osteogenesis imperfecta and P63
in chronic metabolic acidosis P184
during mammalian reproduction SY14
ER specificity SC39
injury stress-response in inbred mice P62
into different implants P18
into novel osteoconductive material P32
role of leptin OR55
bone healing
age and VEGF expression P177
BMP-2 gene therapy P50
effects of TP508 P25
HE 800 as extracellular matrix P38
xenogenic osteocyte immunoglobulins (Osteolin) and P179
see also fracture healing
bone loss
alcohol intake and SC24
antiretroviral therapy-induced SC32
apolipoprotein E genotype and P139
in burns trauma, GH treatment and P68
Ca intake and mechanical strain and P526
in corticosteroid-treated patients P456, P457
dietary effects on postmenopausal P378
in edentulous and dentate mandible P525
ERalpha genotype and P141
in estrogen deficiency OR37
gestational and puerperal, cytokines mediating SY10
in lung transplant candidates P416
in male BERKO mice OR35
prevention of season-related SC18
statin therapy and P535
Tai Chi exercise and P604
TGF-beta1 polymorphisms and P137
bone marrow
cells, caveolin-1 P219
formation, PTH/PTHrP receptor signaling and OR56
mononuclear cells (BMMNC), developmental markers P216
osteoblastic cells, plus novel porous hydroxyapatite P235
osteoprogenitors, MK801 actions OR24
TGF-beta2 and adipocyte differentiation SC34
transplantation, serum FGF-2 levels P70
bone marrow stromal cells (BMSC)
BMP expression in long-term culture P209
BMP responsiveness P48
in bone formation disorders P110
effects of old antler P239
estrogen inhibits adipocytic differentiation OR36
in fibrous dysplasia P109
hepatocyte growth factor and 1,25-dihydroxyvitamin D P248
new in vivo model P257
PPAR gamma P259
see also osteogenic precursor cells
bone mass
in Addison's disease P69
after exercise in postmenopausal women P482
age-related changes in whole bones P440
assessment methods P334
in asthmatic children P453
balance and posture measures and P424
bone strength prediction in growing animals P439
Ca intake and physical activity and P435
calcitonin receptor Alu I polymorphism and P143
in coronary atherosclerosis P411
ethnic differences in South African children P126
in inflammatory bowel disease P498
and lipid profile in healthy men P418
in mechanically unloaded p53 knockout mice P480
in mothers of term and pre-term infants P354
nutrition in postmenopausal women and P473
in oophorectomized rats with renal failure P124
peak see peak bone mass
peripheral, risk stratification by P423
in peripheral arterial occlusive disease P494
reference values in Hong Kong Chinese P395
regulation by leptin OR74
TGF-beta1 polymorphisms and P137
in treated chronic hepatitis C P72
see also bone mineral content; bone mineral density
bone matrix
osteocalcin release P261
transcytosis in bone-resorbing osteoclasts P282
zinc mapping P256
bone metabolism
coffee intake and P461
in congenital hip dysplasia P406
during mammalian reproduction SY14
exercise in premenopausal women and P484
in healthy elderly P358
in HIV infection P502
infliximab therapy and P353
in liver transplant recipients P101
in mother-daughter pairs P407
raloxifene therapy in men and OR31
in type 2 diabetes mellitus P78
see also bone turnover markers
bone metastases
BMP and BMPR expression P51
breast cancer see breast cancer, metastatic
MAP kinase signaling OR49
mechanisms of osteolysis IN12, P161
osteoblastic, in prostate cancer P120
bone mineral content (BMC)
age and gender differences at lumbar spine P441
in anorexia nervosa and athletes P486
dietary factors in premenopausal women P388
GH therapy and P536
in Italian and Danish women P383
long bones of fetal sheep, maternal nutrition and P387
bone mineral density (BMD)
absence, in drug-refractory epilepsy P437
age at menarche and P391
alendronate therapy and P550, P556
androgen actions OR38
androgen receptor and ER genotypes and P127
ankle fractures and P426
in ankylosing spondylitis P83
in anorexia nervosa P468, P486
antihypertensive therapy and P531
assessment in clinical practice P325
in athletes P486
BMP-6 treated osteoporotic rats OR67
in bone marrow transplant recipients P70
bone resorption markers and P343
breast cancer risk and SC23
in brittle mouse model P66
in calcium oxalate stone formers, HRT and P491, P509
in cardiac transplant patients SC31
in celiac disease P500
central versus peripheral P306
COL1A1 Sp1 polymorphism and OR9, SC29, P132, P138
in copper deficiency P521
dietary effects in premenopausal women P388
in elderly hip fracture patients P578
ER specificity SC39
exercise in premenopausal women and P484
extracorporeal shock wave therapy and P445
in females in Moscow P304
femoral neck see femoral neck, BMD
fermented soybeans and P589
and fracture risk, musculoskeletal factors in variance P429
functional recovery after hip fracture and P627
in glucocorticoid-treated asthma P457
hand osteoarthritis and P415
in head and neck cancer survivors P404
ibandronate therapy and P545
Icelandic linkage study OR10
IL-6 gene polymorphisms and P134
in Italian and Danish women P383
limbs and pelvis in Henan province P328
long bones of fetal sheep, maternal nutrition and P387
loss see bone loss
low see osteopenia
lumbar spine see lumbar spine, BMD
menopausal age and BMI and P307
methotrexate and P508
in mother-daughter pairs P407
in mucopolysaccharidosis type IV P104
in Parkinson disease P414
peripheral fracture rate and P397
in peritoneal dialysis patients P73
in postmenopausal Mapuche women P386
in postmenopausal women on HRT, and smoking P398
in pregnancy and lactation P26
premature menopause and P515, P516
in primary hyperparathyroidism P57
Pronosco X-posure System P335, P336, P337
proximal femur see femur, proximal, BMD
in rheumatoid arthritis P490
rhPTH therapy in ovariectomized monkeys and P626
statins and OR13
surgical treatment of obesity and P463
as surrogate for fracture risk SC13
in systemic lupus erythematosus P444
TGF-beta1 genotype and P140
in thrombopoietin receptor knockout mice OR58
in treated prostate cancer P121
VDR Fok I polymorphism and P650
VDR genotype and lifestyle interactions P504
in vitamin D deficiency P470, P582
vitamin D and PTH relationship and P584
in young Croatian adults P301
zoledronic acid and OR80
see also bone mass; digital X-ray radiogrammetry; dual energy X ray absorptiometry; quantitative ultrasound
bone modeling units (BMU), regulation of coupling by fluid flow P43
bone morphogenetic protein 2 (BMP2)
adenovirus mediated gene therapy P50
in calcific tendinitis of shoulder P8
in osteophyte formation P49
phosphate transport and P47
proteasome inhibitor actions OR19
responsiveness of human marrow stromal cells P48
statins and OR22
bone morphogenetic protein 4 (BMP4), muscle-derived stem cell transduction OR21
bone morphogenetic protein 6 (BMP6)
expression in osteogenesis OR26
in osteoporotic rats OR67
bone morphogenetic protein 7 (BMP7), in ectopic and orthotopic osteogenesis P53
bone morphogenetic protein receptors (BMPR)
in calcific tendinitis of shoulder P8
in osteophyte formation P49
in tumors P51
bone morphogenetic proteins (BMPs)
in bone marrow stromal cells P209
in osteophytes P39
regulation by PTH P52
in traumatic brain injury P85
in tumors P51
bone pain, electroalgometry P313
bone remodeling
during mammalian reproduction SY14
in kidney transplant patients P75, P87
in metastatic breast cancer P154
recombinant IL-1-beta and P266
therapeutic ultrasound and P243
bone resorption
alpha v beta 3 integrin and SC5, OR69
antiretroviral therapy-induced SC32
apical exocytosis of lysosomal proteins P282
clodronate-mediated inhibition P291
control by ODF (RANKL) P265
estradiol and raloxifene effects P295
Gap 27 and P289
in hemodialysed postmenopausal women P593
IL-6, LIF and oncostatin M actions P273
IL-17 and OR7
ionotropic non-NMDA receptors and P298
lycopene and P297
mechanical strain and P299
menstrual cycle phase effects P268
in metastatic breast cancer P167
mevastatin and OR70
milk basic protein and P538
non-NMDA receptors and P298
in Osf2/Cbfa1 overexpressing mice OR25
osteocalcin release from bone matrix P261
osteoclast size and P280
in pamidronate-treated breast cancer P151
in postmenopausal women P343, P345
RGD-insulin and P262
serum TRAP 5B as marker P350, P351
vegetarian diet and P524
bone scintigraphy, in Paget's disease P116
bone sialoprotein (BSP) see osteocalcin
bone strength
bone mass measurements predicting P439
in brittle mouse model P66
effects of leptin OR73
effects of zinc P41
rhPTH(1-34) and OR66
strontium ranelate and P537
bone tumors
cartilagenous, PET scan P158
primary, mast cell assessment P159
bone turnover markers
in adolescent pregnancy P436
alendronate therapy and P556, P614
in anorexia nervosa P382
apolipoprotein E genotype and P139
calcitonin therapy and P580
in chronic hepatitis C P72
in Crohn's disease P71
effect of feeding P357
in etidronate therapy monitoring P608
ibandronate therapy and P615
infliximab therapy and P353
lasofoxifene and P594
in men with vertebral fractures P513
in metastatic breast cancer P167, P169
methotrexate and P508
for monitoring treatment response P613
in monoclonal gammopathies of unknown significance P164
in mothers of term and pre-term infants P354
in multiple myeloma P164
in Paget's disease P116
in peritoneal dialysis patients P73
in postmenopausal women P344, P345, P346
in pregnancy P389
prolonged recombinant IL-1 beta therapy and P266
puberty, aging and gender effects P505
in renal osteodystrophy P86
in renal transplant recipients P506
repeat-test reliability P356
smoking and, during HRT P591
stability during storage and mailing P355
subcutaneous estradiol implant and P597
vitamin D and PTH relationship and P584
see also bone metabolism
boron, urinary, in postmenopausal women P349
brachiopods, atremate P6
brain injury, traumatic, heterotopic ossification P85
Brazil
COL1A1 Sp1 polymorphism and BMD in women P138
epidemiology of osteoporosis P373
breast cancer
BMD and risk SC23
bone sialoprotein expression P163
Ca-induced estrogen-like activity P165
cells, capacitative Ca influx P156
metastatic
bone turnover markers P167, P169
expression markers P153
genes regulating P162
histomorphometric analysis P154
ibandronate and P149
mechanism of osteolysis IN12, P161
monitoring behavior P152
NF-kB in OR46
urinary L-galactosylhydroxylysine P166
osteoporosis and P511
pamidronate therapy P151
regulation of PTHrP expression P58, P59
breast-feeding see lactation
brittle mouse model, osteogenesis imperfecta P66
bulimia, fractures in OR18
burns, GH treatment in children P68
C3H/HeN mice P62
Ca see calcium
calcaneus
extracorporeal shock wave therapy P445
ultrasound see quantitative ultrasound (QUS), calcaneus
calcification
arterial, in cholesterol fed rabbits P5
atherosclerotic, OPG and OPGL P80
eggshell, genes involved SY7
rotator cuff tendons P8
calciotropic hormones
in avian skeleton SY5
in healthy elderly P358
calcipenia, PTH secretion in streptozotocin-diabetic rats P190
calcitonin
equine, cloning SY12
in male osteoporosis P579
nonvertebral fracture risk reduction P565
in postmenopausal osteoporosis
biochemical marker and pQCT changes P581
DEXA and pQCT changes P580
quality of life evaluation P631
versus other therapies P552
protein kinase C activation P144
tendon healing and P142
calcitonin gene-related peptide (CGRP)
equine CGRP-I and CGRP-II SY12
protein kinase C activation P144
receptors, novel OR44
calcitonin receptor (CTR)
gene, Alu I polymorphism P143
GFP constructs P281
isotype 2 (CTR2) OR44
calcitriol see 1,25-dihydroxyvitamin D3
calcium
in avian skeleton SY5
capacitative influx
1,25(OH)2D3 induced P253
breast cancer cells P156
dietary requirements SY19
estrogen-like activity in breast cancer P165
homeostasis
in osteoporosis P584
sweat loss in horses and SY16
importance to bone throughout life SY18
intake
bone mass at 36 years and P435
from milk and dairy products P384
Na/Ca exchanger and Ca pump activities and P651
in ovariectomized rats P526
intestinal absorption
oxidative stress and P146
isotope ratios, measurement P322
metabolism, role of scales in fish SY4
puringergic signaling pathway, olpadronate/ IG-9402 and P252
regulating factors in fish SY3
regulatory pathways, in endochondral bone formation P11
serum ionized, in equine enterocolitis and hypocalcemia SY15
supplementation
in adolescent pregnancy P436
in Crohn's disease P563
GP's knowledge about P640
osteoporotic fracture healing and P641
in renal failure P148
in rickets in Nigeria P95
serum lipid effects in postmenopausal women P586
timing, dose and choice SY21
versus treatment SY20
in vitamin D deficiency P469, P585
winter time SC18
in young dogs P64
supplemented yoghurts, for elderly P462
transepithelial flux, in crustacean molting SY1
urinary excretion
in diabetic osteoporosis P413
in equine enterocolitis and hypocalcemia SY15
HRT in calcium oxalate stone formers and P509
in postmenopausal women P349
raloxifene and P600
vitamin A and vitamin D interactions P652
calcium-ATPase (Ca pump)
in chick enterocytes P651
plasma membrane see plasma membrane calcium-ATPase
calcium-dependent potassium current, osteoclast spreading and P300
calcium oxalate stone formers, estrogen therapy P491, P509
calcium-sensing receptor
in calcium-supplemented renal failure P148
glucose concentration and P145
new mutation P147
CALCR gene polymorphism, osteoporosis in postmenopausal women and P410
callus, soft, in fracture repair P493
calvaria, mouse, bone formation induced by canine prostate P120
Cameroon, hip and wrist fractures P425
CAM kinase II (CaMKII) OR72
cAMP suppression test, urinary, in osteoporosis P492
Camurati-Engelmann disease OR59, P287
Canada, seasonal variations in 25OHD and PTH P464
Canadian Database of Osteoporosis and Osteopenia (CANDOO) P628
cancellous bone see trabecular bone
carbon tetrachloride-induced hepatic osteodystrophy P635
cardiac transplantation, serum osteoprotegerin after SC31
carnitine derivatives, trophic effect on osteoblasts P242
cartilage
BMP-2 and BMP receptor in osteoarthritic P49
degradation, role of IL-17 OR7
matrix formation P17
see also epiphyseal growth plate
cartilagenous bone tumors, PET scan P158
caspase-3, in bisphosphonate-induced apoptosis P290
cat see feline
catecholamines, and PTH in endurance exercise P183
cathepsins
osteoprotegerin-mediated stimulation SC4
stimulation by hGH P260
caveolin-1, in osteoblasts P219
Cbfa1 IN6
effect of TP508 P25
mice overexpressing OR25
Cbl, Src interaction OR2
CD49a, osteogenic precursor cells P216
CD166 (ALCAM)
osteogenic precursor cells P216
celiac disease, bone density and fractures P500
cell death pathways, in endochondral bone formation P11
cell differentiation, 1alpha,25(OH)2D3-induced SC35
cell-matrix interface in bone P247
centrosomal microtubule organizing centers, osteoclast P284
cerebral palsy, pamidronate therapy P572
cerivastatin
inducing bone-specific genes in preadipocytes P208
in ovariectomized rats P517
cGMP, osteoblast differentiation and P229
chair, rising from, in fracture prediction SC16
chemotherapy, sensitization of cells to apoptosis OR50, P160
chest radiograph, to predict hip BMD P314
chick enterocytes, sodium/calcium exchanger and Ca-ATPase activities P651
chicken tibia model, prediction of fracture load P361
children
alendronate therapy of osteoporosis P609
Ca treatment of rickets in Nigeria P95
drug-refractory epilepsy P437
ethnic differences in bone mass P126
fluoride and aluminium intoxication P91
GH treatment after burns P68
HIV infection SC32
obese OR55
post-liver transplantation P101
QCT in pre- and post-pubertal female P433
spine and hip BMD in Japanese P434
China
age- and sex-specific reference bone mass values P395
alendronate for vertebral fractures P566
BMD studies P328
Han women, ER genotypes P514
lifetime occupation and hip BMD in elderly men P374
Chinese herbal preparation, in ovariectomized rats P606
cholesterol-rich diet, arterial calcification P5
chondroblastic tissue culture, novel spontaneously differentiating P12
chondrocytes
apoptotic, in growth plate P29
retinoic acid regulation in deer antlers OR60
strontium ranelate and P17
chrome-cobalt-molybdenum implants, bone ingrowth P18
chronic disorders, hypovitaminosis 1,25(OH)2D3 P643
cirrhosis, primary biliary, alendronate versus etidronate P543
clavicle radiogrammetry, to predict hip BMD P314
clodronate
actions in osteoclasts P291
metabolism in macrophages P292
coeliac disease, bone density and fractures P500
coffee intake, bone metabolism and P461
COL1A1-CRE transgenic mice, osteoblast gene targeting OR57
COL1A1 Sp1 polymorphism
BMD and osteoporotic fractures and OR9
fractures in liver transplant patients and P135
osteoporosis in men and P479
osteoporosis and osteoarthritis in older adults and P136
postmenopausal osteoporosis and P128, P410
COL1A2 Msp1 polymorphism, osteoporosis in men and P477
colchicine, for osteoporosis P607
collagen
fiber orientation in cortical bone P45
-induced arthritis, type 2, incadronate therapy P24
mineralization in distraction osteogenesis P222
type I
C-terminal telopeptide, puberty, aging and gender effects P505
N-terminal telopeptide (NTX), urinary, effect of storage and mailing P355
in Paget's disease P118
Sp1 polymorphism see COL1A1 Sp1 polymorphism
telopeptide derived degradation products P343
type II, effect of TP508 P25
type III
in osteoarthritis P36
in Paget's disease P118
Colles' fractures see forearm fractures, distal
compliance
hip protector use P611
osteoporosis therapies P610, P618
computed tomography (CT)
micro- see micro-CT
quantitative see quantitative computed tomography
spiral, parathyroid adenoma localization P60
confocal microscopy, osteoclasts P283
congenital hip dysplasia, osteoporosis and bone metabolism P406
connective tissue diseases, differential diagnostics P102
connexin43 (Cx43)
breast cancer metastasis and P153
deficiency, impaired osteoclastogenesis OR5
PTH stimulation of osteoblasts and SC37
connexin-mimetic peptide (Gap 27), osteoclastic bone resorption and P289
consanguineous family with osteoporosis P130
copper deficiency, oxidative parameters and BMD P521
coronary atherosclerosis, bone mass in men with P411
cortical bone
collagen fiber orientation P45
effects of h-PTH (1-34) in diabetic rats P624
strength
assessment using DXR SC33
effects of rhPTH(1-34) therapy OR66
hip fractures and SC26
corticosteroids see glucocorticoids
cost-effectiveness
osteoporosis diagnostic approaches P629
osteoporotic fracture prevention SC14
costs, osteoporosis treatment in Ecuador P623
coxarthrosis, protection against hip fracture P451
cranio-facial skeleton
fibro-osseous lesions P107
genetic basis of development IN14
craniosynostosis SC11
Cre/loxP technology, osteoblast gene targeting OR57
Croatia
BMD in young adults P301
bone histomorphometry P432
Crohn's disease
bone histomorphometry P81
bone mass in men P498
bone turnover markers P71
osteoporosis treatment P563
crustacean molting, role of SERCAs and PMCAs SY1
CTGF/Hcs24, in OPLL patients P15
cursorial animals, osteon population densities in limb bones P446
CUT 2000 (cementless hip system) P1
cyclic AMP suppression test, urinary, in osteoporosis P492
cyclic GMP, osteoblast differentiation and P229
cyclic stretch, spinal ligament cells from OPLL P16
cyclosporin, in renal transplant recipients P506
CYP1, bone cell regulation P646
CYP19 mutations P512
CYP24, bone cell regulation P646
cystatin C, renal function and P507
cystein-rich protein 61 (CYR61)
in enhanced bone formation P203
in osteogenic differentiation P207
cytokines
in bone loss of pregnancy and puerperium SY10
eNOS activation P231
inflammatory, role in osteoclasts IN2
melatonin effects P230
menstrual cycle phase and P268
in monoclonal gammopathies of unknown significance P164
in multiple myeloma P164
in osteoporosis P175
see also interleukin-6; tumor necrosis factor-alpha; other specific cytokines
Czech women, VDR Fok I polymorphism and BMD P650
daidzein, effects on osteoblasts P599
Danish Osteoporosis Prevention Study OR27, P302, P587
Danish women, BMD and BMC P383
Dark Agouti (DA) rats, type 2 collagen-induced arthritis P24
deer antlers, retinoic acid receptors OR60
degenerative joint disease, in pigs P106
DeltaFosB proteins OR20
dentin phosphophoryn, dephosphorylation P7
dentin sialophosphoprotein, in osteoblasts P206
deoxypyridinoline, urinary, for monitoring treatment response P613
desmoid tumor, BMP and BMPR expression P51
developing countries
cost of osteoporosis treatment P623
screening for postmenopausal osteoporosis P314
DEXA see dual energy X ray absorptiometry
dexamethasone
adrenomedullin and adrenomedullin receptors and P202
dependent osteoprogenitors, in ovariectomized rats P258
effects on mouse bones P196
pathogenesis of osteoporosis P254
serum osteocalcin levels and P459
diabetes mellitus
BMD, role of urinary Ca P413
eSS rats, bone geometry and biomechanics P89
osteopenia and diabetic foot development P402
streptozotocin-induced see streptozotocin-diabetic rats
type 1 (IDDM)
BMD at time of diagnosis P443
pathogenic aspects of osteopenia P403
type 2
markers of bone metabolism P78
osteoporosis and P79
serum undercarboxylated osteocalcin in osteoporosis P376
dialysis
serum Mg predicting PTH levels P122
serum propeptides of type I procollagen P86
toxic role of osteoprotegerin P76
see also hemodialysis; peritoneal dialysis
diaphyseal dysplasia, progressive OR59
diet
bone resorption in rats and P524
Ca and vitamin D requirements SY19
cholesterol-rich, arterial calcification P5
isocaloric low protein OR17
net endogenous noncarbonic acid production (NEAP) intake SC17
postmenopausal bone loss from spine and P378
postmenopausal spinal osteoarthritis and P499
in psychological disability P472
radius fractures and P381
vegetarian versus fish-meal, in pigs SY17
digital X-ray radiogrammetry (DXR) P337
assessing effects of rhPTH(1-34) SC33
on mammographic X-ray equipment P336
predicting fracture risk SC15
short-term in-vivo precision P335
versus DXA and QUS P334
1,25-dihydroxyvitamin D3 (1,25(OH)2D3)
20-epi analogs IN16
alendronate interaction P250
A-ring analogs SC35
capacitative cation entry and P253
in carbon tetrachloride-induced hepatic osteodystrophy P635
hepatocyte growth factor and P248
in institutionalized epileptic patients P638
in oophorectomized rats with renal failure P124
osteoprotegerin and P170
in pregnancy P389
in renal osteodystrophy P77
signaling in muscle cells P653
in streptozotocin-induced diabetic rats P655
VDR expression and P649
disability, before and after vertebral fractures P394
distraction osteogenesis
collagen mineralization P222
early response gene expression P221
pQCT for assessment P2
DMBA, in estrogen replete ovariectomized rats P528
DNA methylation, PTHrP in breast cancer cells P58
DNA microarrays
estrogen-treated osteoblasts P199
osteoblast related genes SC6
dog
Ca and P supplementation in young P64
prostate tissue, inducing bone formation P120
dolomite, natural Brazilian, for osteoporosis P373
Down syndrome, mandibular bone structure P125
DRIPs (vitamin D receptor interacting proteins) IN16
dual energy X ray absorptiometry (DEXA, DXA)
accuracy of weight estimation P321
in asthmatic children P454
between-machine differences P310, P338
bone strength prediction in growing animals P439
calcitonin therapy and P580
in clinical practice P325
education program after P619
frequency in peri- and postmenopausal women P302
in mucopolysaccharidosis type IV P104
PA versus lateral lumbar spine P332
in peritoneal dialysis patients P88
phantoms for infants P438
physiological versus true osteopenia P308
versus digital X-ray radiogrammetry P334
early response genes, mechanically stimulated bone regeneration system P221
eating disorders OR18
see also anorexia nervosa
economic analysis
osteoporosis diagnosis P629
see also cost-effectiveness
Ecuador, cost of osteoporosis treatment P623
edentulous mandible, bone loss P525
educational program, after osteoporosis screening P619
EEA1, in osteoclasts OR4
eggshell calcification, genes involved SY7
Ehlers Danlos syndrome, differential diagnostics P102
elderly
bone metabolism and calciotropic hormones P358
calcium/vitamin D-supplemented yoghurts P462
COL1A1 Sp1 polymorphism and osteoporosis and osteoarthritis P136
hip fracture patients, BMD changes and calcitonin therapy P578
hypovitaminosis D in hospitalized P643
osteoblastic function in hospitalized P501
osteoporosis education program P619
PTH status in hypovitaminosis D P644
see also aging
elderly men
lifetime occupation and hip BMD P374
raloxifene therapy OR32
elderly women
BMD and balance and posture measures P424
hip fractures
BMD and functional recovery P627
risedronate for prevention P547
vitamin D status P385
hip protectors for community-dwelling P611
periosteal alkaline phosphatase P212
rehabilitation/exercise program P605
see also postmenopausal women
electrical stimulation, osteoblasts in vitro P236
electroalgometry P313
electromagnetic field stimulation
osteoblasts P241
in osteoporosis P534
in ovariectomized rats P533
enalapril
BMD and P531
skeletal effects P518
endochondral ossification P11, P12
absence in growing frogs P19
FACS analysis of matrix vesicles P13
endonucleases, zinc staining P46
endothelin-1 (ET-1), in metastatic bone cancer IN12
endothelium, vascular, osteoclast precursor recruitment P286
enterocolitis, in horses SY15
enterocytes
PTH signaling P185
sodium/calcium exchanger and Ca-ATPase activities P651
enzyme therapy, and alendronate, in ovariectomized rats P555
epilepsy
calcitriol in institutionalized patients P638
drug-refractory, absent bone mass P437
epiphyseal growth plate
alendronate in osteogenesis imperfecta and P63
chondrocyte apoptosis P29
matrix vesicles P13
zinc staining P46
equine
calcitonin, CGRP-I and CGRP-II cDNAs SY12
distal cannon bone, response to exercise P44
enterocolitis and hypocalcemia SY15
osteocalcin P220
sweat loss and Ca and Mg homeostasis SY16
ER see estrogen receptors
esophagus
irritation by bisphosphonates SC22
transit of alendronate tablets P551
eSS diabetic rats, bone geometry and biomechanics P89
estradiol (17-beta estradiol, E2)
in eNOS and nNOS knockout mice P194
genomic effects in osteoblasts P199
IL-6 and P174
in men with vertebral fractures P513
osteoclast differentiation and P295
osteogenic response in BERKO mice SC38
plus vitamin D-enhanced osteoblast differentiation P200
raloxifene response in elderly men and OR32
regulation of IGF-I and IGFBP-5 SC7
serum, ERalpha genotype and P141
subcutaneous implants, serum beta-crosslaps and P597
estrogen
deficiency, mechanism of bone loss OR37
excess synthesis, effects on bone P474
genomic effects in osteoblasts P199
-like activity of Ca in breast cancer P165
in oophorectomized rats with renal failure P124
plus hPTH 1-34 therapy OR30
replacement therapy see hormone replacement therapy
suppression of osteoclast formation SC3
trabecular bone effects in male mice OR38
estrogen receptor alpha (ERalpha)
in avian medullary bone SY8
in estrogen regulation of osteoblasts P201
genotypes
and BMD in men P127
in postmenopausal women P141
mediation of estrogen actions SC39
regulation of IGF-I gene SC40
estrogen receptor beta (ERbeta)
in avian medullary bone SY8
in estrogen regulation of osteoblasts P201
knockout (BERKO) mice
male OR35
osteogenic response to 17beta-estradiol SC38
mediation of estrogen actions SC39
RsaI polymorphism, alendronate and P561
estrogen receptors (ER)
genotype
alcohol intake and SC24
BMD in Chinese Han women and P514
in transsexual men P133
ligands, molecular pharmacology IN11
regulation of female skeleton SC39
estrogen related receptor (ERRa) OR71
ethinyl estradiol and norethindrone acetate, in postmenopausal women P598
ethnic differences
bone mass in South African children P126
hip fracture risk P377
etidronate
intermittent cyclical (ICE)
alendronate after P549
biochemical markers of efficacy P608
in male osteoporosis P540
in osteoporosis SC20
in primary biliary cirrhosis P543
in rheumatoid arthritis P571
Ets1 and Ets 2 genes SC6
European Prospective Osteoporosis Study (EPOS) P392
European reference data, QUS in pediatric patients P367
evolution, vertebrate limb IN17
exercise
in elderly women P605
endurance, plasma catecholamines and PTH P183
home isometric resistive, in osteoporosis P603
IGF-I and IGFBP-3 levels and P483
in postmenopausal osteopenic women P482
in premenopausal women P484
QUS parameters and P487
response of horse distal cannon bone P44
stopping, QUS in pre- and postmenopausal women P488
Tai Chi, in postmenopausal women P604
see also physical activity
exocytosis, apical, in bone-resorbing osteoclasts P282
extracorporeal shock waves, calcaneal bone density and P445
fa/fa rats OR74
falls, genetic factors OR11
familial hypercalciuric hypocalcemia P147
farnesyl diphosphate (FPP) synthase SC1, SC2
fatigue microdamage
limb bones of cursorial animals P446
in proximal femur P22
fat mass, in mucopolysaccharidosis type IV P104
FC1271A, versus raloxifene P601
feeding, bone turnover markers and P357
feline
head and neck squamous cell carcinoma line P55
preproparathyroid hormone SY11
femoral head implants, wear debris mediated osteolysis P33
femoral neck
BMD
hip fracture risk and P392
in Japanese boys and girls P434
versus total hip BMD P327
fractures see hip fractures
genetic factors in osteoporosis P129
periosteal alkaline phosphatase P212
femur
biomechanics
in eSS diabetic rats P89
in hypobaria P40
fracture healing, effects of TP508 P25
strength, in brittle mouse model P66
femur, proximal
BMD
in females in Moscow P304
in Japanese boys and girls P434
lifetime occupation in elderly Chinese men and P374
menopausal age and BMI and P307
prediction from clavicle radiogrammetry P314
and protein nutrition in postmenopausal women P375
versus femoral neck BMD P327
vertebral fractures and P326
fractures see hip fractures
microdamage and IL-6 and CTR expression P22
fermented soybeans, skeletal effects P589
FGF see fibroblast growth factor
fibroblast growth factor 2 (FGF2)
prostaglandin-mediated regulation SC44
Runx2 expression and P211
serum, in bone marrow transplant recipients P70
Twist interaction SC11
fibroblast growth factor 23 (FGF23), as cause of hypophosphatemia OR78
fibroblast growth factor receptor 2 (FGFR2)
prostaglandin-mediated regulation SC44
Runx2 expression and P211
fibroblast growth factor receptor 3 (FGFR3) gene mutations, STAT1 activation OR53
fibroblasts
in calcific tendinitis of shoulder P8
effects of melatonin P230
fibromodulin-biglycan double knockout mice OR54
fibronectin, EIIIA segment P34
fibro-osseous lesions, cranio-facial bones P107
fibrous dysplasia of bone
age dependent death of mutated stem cells P109
angiogenesis and alpha-SM actin expression P108
BMP and BMPR expression P51
Finnish men, androgen receptor and ER alpha genotypes P127
fish
Ca regulating factors SY3
pectoral fin development IN17
role of scales in Ca metabolism SY4
fish-meal diet, versus vegetarian in pigs SY17
FITC labeling, immunolocalization of osteocalcin P35
fitness, exercise in premenopausal women and P484
FK506 (tacrolimus)
osteoblast differentiation and P204
in renal transplant recipients P506
Florida, United States, seasonal variations in vitamin D P645
Flt3 ligand, in osteoclast differentiation and function P270
fluorescence activated cell sorting (FACS), matrix vesicles P13
fluoride
and aluminium intoxication P91
apatite formation in poly(vinylalcohol) gel and P529
in glucocorticoid-induced osteoporosis in male rats P573
osteoblast apoptosis and P197
focal adhesions
mechanical strain effects P224
osteocytes P30
food intake see diet
foot
algo-dystrophy P67
diabetic, diabetic osteopenia and risk P402
forearm, distal
BMD in ankylosing spondylitis P83
BMD in rheumatoid arthritis P490
forearm fractures, distal
in Cameroon P425
lifestyle, anthropometric and menstrual factors P381
in men SC27
osteoporosis intervention OR65
prevention by HRT OR27
c-Fos
in bone cell differentiation IN15
in mechanically stimulated bone regeneration system P221
Fra-1
in bone cell differentiation IN15
overexpressing mice, bone nanostructure P205
fractal analysis, cancellous bone P448
fractal dimension, trabecular bone P452
fracture healing
age and VEGF expression P177
biology of soft callus P493
cystein-rich protein 61 and P203
Osteolin and P179
vitamin D and Ca in osteoporotic P641
see also bone healing
fracture healing stimulin (Jin Pu Ye) P198
fracture intervention trial (FIT) P405, P576
fractures
in asthmatic perimenopausal women P409
blood pressure and, in men P475
BMD and, musculoskeletal factors in variance P429
in celiac disease P500
in cerebral palsy P572
COL1A1 Sp1 polymorphism and OR9
densitometric measurement method and P331
in eating disorders OR18
epidemiology IN5
in England and Wales SC25
in Harbin Orthopedic Surgery Hospital P393
gender differences IN4
genetic effects on falls risk and OR11
in liver transplant patients P135
load prediction, in chicken tibia model P361
in mother-daughter pairs P407
multiple, physical impairment and P427
with normal DEXA BMD, ultrasound measures P372
osteoporosis intervention after OR65, P621
osteoporosis risk assessment after P364
peripheral, axial and peripheral BMD and P397
in peritoneal dialysis patients P73
in pituitary diseases P399
prevention
alendronate P576
alendronate, calcitonin and alfacalcidol P565
clinical trials IN9
cost-effectiveness SC14
GP's knowledge of Ca and vitamin D preparations P640
HRT P592
rhPTH(1-34) therapy SC12
risedronate P577
role of leptin OR73
risk prediction
bone formation versus resorption rates P352
change in BMD SC13
digital X-ray radiogrammetry SC15
previous fractures OR14
sit-to-stand test SC16
ultrasound P339
socioeconomic deprivation and P401
TGF-beta1 genotype and P140
see also specific types of fractures
frog, lack of endochondral ossification P19
gait impairment
in biglycan-fibromodulin knockout mice OR54
in hereditary tyrosinemia type 1 (HT-1) P84
L-galactosylhydroxylysine, urinary, new assay P166
Gap 27, osteoclastic bone resorption and P289
gap junctions
breast cancer metastasis and P153
see also connexin43
gastric ulcers, risedronate versus alendronate P546
gastrointestinal symptoms, upper see upper gastrointestinal (GI) symptoms
Geelong osteoporosis study OR13
gender differences
BMC distribution in lumbar spine P441
bone densitometry referrals P612
bone and muscle development at puberty P21
bone turnover markers P505
distal radius structure P431
fracture risk SC25
osteoporosis diagnosis IN8
Paget's disease P119
QUS of os calcis P3
spine and iliac crest histomorphometry P340
gene chips see DNA microarrays
general practitioners (GPs), knowledge of Ca and vitamin D preparations P640
gene therapy
BMP-2 P50
BMP4 transduced muscle-derived stem cells OR21
genetics
breast cancer metastasis P162
craniofacial development IN14
degenerative joint disease in pigs P106
falls OR11
ossification of posterior longitudinal ligament P14
osteoporosis and BMD OR10
osteoporosis in postmenopausal women P410
osteoporosis in young people P129
Paget's disease of bone IN13, OR52
trabecular bone density and architecture OR12
genistein, genomic effects in osteoblasts P199
geranylgeranyl transferase II SC2
GH see growth hormone
giant cell tumor cells, MSP receptor/RON expression P279
Gli3, proteasome inhibitor actions OR19
glucocorticoid-induced osteoporosis
ibandronate therapy OR68
longitudinal study P456
minipig model P455
osteoprotegerin/osteoprotegerin ligand and P272
prophylaxis in clinical practice P460
rat model
alendronate versus fluoride P573
microstructural changes P519
role of tyrosine phosphatases P254
glucocorticoids
in asthma, effects on bone P454, P457
community use in Iceland P460
inactivation in osteoblasts OR23
in osteopetrosis P98
risedronate for men on P548
risedronate for postmenopausal women on P568
see also dexamethasone
glucose
calcium-sensing receptor sensitivity and P145
impaired fasting, alendronate and P541
glutamate receptors
in osteoblasts OR72
osteoclast resorption and P298
gnatho-diaphyseal dysplasia P107
goat, osteoporotic P523
Goettinger (Gottingen) minipigs
bone ingrowth into implants P18
glucocorticoid-treated P455
granulocyte colony-stimulating factor (G-CSF), in Kostmann's syndrome P311
"Gran-White", for osteoporosis P373
green fluorescent protein (GFP) constructs P186, P281
growth, bone see bone growth
growth hormone (GH)
in animal model of frailty OR17
in children with burns P68
in hyperthyroidism with osteoporosis P412
in hypophysectomized rats P539
IGF-I-mediated proteinase activation P260
postoperative therapy in hip fractures P536
hand
X-rays, digital X-ray radiogrammetry SC15, P335, P336, P337
osteoarthritis, osteoporosis and P415
Han women, Chinese, ER genotypes P514
Harbin Orthopedic Surgery Hospital, fracture epidemiology P393
HE 800, bone healing and P38
head injury, heterotopic ossification P85
head and neck cancer, reduced BMD in survivors P404
head and neck squamous cell carcinoma line, feline P55
healing see bone healing; fracture healing; tendon healing
health related quality of life see quality of life
Hedrocel, bone growth in P32
HEK293 cells, calcitonin receptor-GFP constructs P281
Helicobacter pylori status, risedronate versus alendronate and P546
hematopoiesis, PTH/PTHrP receptor signaling and OR56
hemodialysis
raloxifene for postmenopausal women on P593
Henan Province, China, BMD of limbs and pelvis P328
hens, osteoporosis in laying SY6
heparan sulfate proteoglycan, in differentiating osteoblasts P37
heparin
-binding growth factors, in osteogenic differentiation P207
low-molecular-weight, skeletal effects P527
heparin-binding growth-associated molecule (HB-GAM), mechanical strain effects P227
hepatic osteodystrophy, carbon tetrachloride-induced P635
hepatitis C, chronic P72
hepatocyte growth factor (HGF)
1,25 dihydroxyvitamin D and P248
prevention of renal ischemia OR42
hereditary tyrosinemia type 1 (HT-1) P84
high altitude, biomechanical properties of rat femurs P40
high-performance liquid chromatography, with electrochemical detection P348
hip
congenital dysplasia P406
geometry, hip fracture risk and P392
osteopenia, in ochronosis P97
protectors, acceptability and compliance P611
strength analysis (HSA), hip fracture risk and P392
see also femur, proximal
hip fractures
BMD in elderly patients after P578
calcitonin therapy P578
in Cameroon P425
causes of osteoporosis in men P478
cortical bone strength and SC26
in coxarthrosis P451
economics of prevention P629
eNOS expression OR15
functional recovery and BMD P627
hip geometry, BMD distribution and bone strength and P392
in Mapuche Indians P377
mortality P428
periosteal alkaline phosphatase and P212
postoperative GH therapy P536
QUS of os calcis P360
risedronate for prevention P547
risk assessment P417
risk factors OR63
risk score P419
screening for women at high risk P396
sit-to-stand test for prediction SC16
vitamin D for prevention OR33
vitamin D status in elderly women with P385
hip replacement prostheses
new cementless P1
uncemented Spongiosa metal surface P103
wear debris mediated osteolysis P33
histomorphometry, bone
age and gender differences P340
age-related changes P341
in Croatian adults P432
cytokines in osteoporosis and P175
fully automated method P449
in inflammatory bowel disease P81
in metastatic breast carcinoma P154
in normal Koreans P31
phenytoin and alfacalcidol and P450
HIV infection
antiretroviral therapy SC32
bone metabolism markers P502
HLA association, ossification of posterior longitudinal ligament P14
HMG C-A reductase inhibitors see statins
home
intravenous pamidronate therapy P544
isometric resistive exercise, in osteoporosis P603
Honduras, QUS study P362
HOP-26, osteogenic precursor cells P216
hormone replacement therapy (HRT)
3D trabecular microstructure and biomechanical properties and P447
bone resorptive cytokines and P268
bone turnover markers and P613
bone turnover and smoking and P591
in calcium oxalate stone formers P491, P509
ERalpha genotype and response P141
ethinyl estradiol and norethindrone acetate P598
nonvertebral fracture prevention P592
osteoporosis prevention OR27
plus hPTH 1-34 therapy OR30
in postmenopausal osteoporosis P552, P567
side effects and discontinuation rates OR28
smoking and BMD and P398
subcutaneous implants P597
horse see equine
Hox genes IN17
HRT see hormone replacement therapy
HTLV-1 infection P54
human immunodeficiency virus infection see HIV infection
humoral hypercalcemia of malignancy P54, P56
see also parathyroid hormone-related protein
hydrochlorothiazide, BMD and P531
hydroxyapatite (HA)
ceramic, osteoclast-mediated resorption P263
IGF-II supplementation P173
novel porous, plus transplanted osteoblastic cells P235
11b-hydroxysteroid dehydrogenase type 2, targeted overexpression OR23
1alpha-hydroxyvitamin D3 see alfacalcidol
25-hydroxy vitamin D (25OHD)
effects of season P464
in vitamin D-deficient postmenopausal women P585
25-hydroxyvitamin D3 (25 OH D3)-1 alpha hydroxylase
knockout mice P648
mechanism of regulation IN10
hyperalgesia, zoledronic acid and P553
hypercalcemia
alfacalcidol-induced P632
in fluoride and aluminium intoxication P91
of malignancy, humoral P54, P56
hypercalciuria, idiopathic P74
hyperkyphosis, in ankylosing spondylitis P82
hyperparathyroidism
Ca and P supplementation and P64
secondary, in vitamin D deficiency P469, P582
hypertension
BMD and antihypertensive therapy P531
osteoporosis in women with P408
PTH1 receptor and plasma renin activity P187
PTHrP system in renal vessels SC36
hyperthyroidism
with osteoporosis, GH changes P412
QUS to detect bone mass changes P369
hypobaria, biomechanical properties of rat femurs P40
hypocalcemia
familial hypercalciuric P147
in horses SY15
hypogonadal men, testosterone therapy P596
hypoparathyroidism, hypophosphatemic, Ca supplementation and P64
hypophosphatasia, magnetic resonance spectroscopy P111
hypophosphatemia
FGF23 as cause OR78
hypophosphatemic hypoparathyroidism, Ca supplementation and P64
hypophosphatemic oncogenic osteomalacia P90, P94
hypophysectomized rats
GH therapy P539
IGF-I actions P180
hypothalamo-pituitary complex, genes for phosphate homeostasis P471
hypovitaminosis D see vitamin D, deficiency
ibandronate
bone metastases and P149, P168
bone turnover markers and P615
in corticosteroid-induced osteoporosis OR68
in Klinefelter's syndrome P545
Iceland
linkage analysis of osteoporosis OR10
steroid-induced osteoporosis P460
IG-9402, purinergic Ca2+ signaling pathway modulation P252
IGF see insulin-like growth factor
iliac crest histomorphometry
age and gender differences P340
in Croatian adults P432
in normal Koreans P31
immigrants, Middle East, osteomalacia in P466
impaired fasting glucose (IFG), alendronate therapy and P541
implant materials
bone ingrowth into different P18
cytotoxicity testing of NiTi P237
novel osteoconductive material P32
novel porous hydroxyapatite P235
osteoblast adhesion to P244
surface modified titanium P234
implants
hydroxyapatite ceramic, osteoclast-mediated resorption P263
IGF-II supplementation P173
osteoclastogenic markers and loosening P277
ultrasound transmission velocity of osseous site P489
wear debris mediated osteolysis P33
see also hip replacement prostheses
importin B1, in nuclear import of PTHrP P191
INAD, in capacitative cation entry P253
incadronate, in type 2 collagen-induced arthritis P24
Indo-Asians, vitamin D deficiency P469, P582
inductively coupled plasma mass spectrometer (ICP-MS) P322
infants, DEXA phantoms for P438
inflammatory bowel disease
bone histomorphometry P81
bone mass in men P498
inflammatory hyperalgesia, zoledronic acid therapy P553
infliximab, in rheumatoid arthritis P353
injury stress-response, effect on skeletal growth in inbred mice P62
insulin-like growth factor-I (IGF-I)
in animal model of frailty OR17
in chronic metabolic acidosis P184
gene regulation by ERs SC40
hGH-stimulated proteinase activation P260
in hypophysectomized rats P180
in leptin-induced skeletal growth OR55
in metastatic breast cancer OR46
in osteoarthritis and osteoporosis, exercise effects P483
PTH-mediated activation OR41
quantitative RT-PCR P182
regulation by estradiol SC7
serum, fracture risk and OR16
insulin-like growth factor-II (IGF-II), hydroxyapatite interactions P173
insulin-like growth factor binding protein-3 (IGFBP-3), in osteoarthritis and osteoporosis P483
insulin-like growth factor binding protein-5 (IGFBP-5)
in osteoarthritis and Paget's disease P181
regulation by estradiol SC7
integrin alpha v beta 3 (avb3)
non-peptide antagonist OR69
peptidomimetics SC5
interferon-alpha
in chronic hepatitis C P72
in multiple myeloma P150
interleukin-1 (IL-1)
cytoskeletal regulation in osteoclasts OR3
menstrual cycle phase and P268
osteoclast actions IN2
interleukin-1 beta (IL-1-beta), recombinant, prolonged administration P266
interleukin-4 (IL-4), osteoclastogenesis and P264
interleukin-6 (IL-6)
bone allograft and P238
estrogen-mediated effects P174
gene polymorphisms, BMD and P134
in kidney transplant patients P87
menstrual cycle phase and P268
microdamage in proximal femur and P22
microgravity effects P223
in osteoporosis P175
polyethylene and alpha-alumina particles and P171
PTHrP-mediated modulation P172
soluble receptor (sIL-6R), in pregnancy and puerperium SY10
versus LIF and oncostatin M P273
interleukin-11 (IL-11)
JAK/STAT signaling P249
in mechanical stress OR62
interleukin-12 (IL-12), osteoclast formation and OR6
interleukin-13 (IL-13), osteoclastogenesis and P264
interleukin-17 (IL-17), in bone and cartilage catabolism OR7
interleukin-18 (IL-18)
osteoclast formation and OR6
intestinal absorption, calcium see calcium, intestinal absorption
intestinal cells, PTH signaling P185
irritation, by nitrogen-bisphosphonates SC22
isopentenyl diphosphate (IPP) isomerase SC1
Italian women, BMD and BMC P383
JAK/STAT pathway, IL-11 signaling P249
Japan
BMD in spine and hip of boys and girls P434
calcaneal QUS P363
osteoporosis prediction in women P316
VDR genotypes and QUS indices P602
Japanese Population-based Osteoporosis (JPOS) study P589
Jin Pu Ye (fracture healing stimulin) P198
joint pain, electroalgometry P313
joint replacement arthroplasty, osteoporosis risk P366
c-Jun
in bone cell differentiation IN15
in mechanically stimulated bone regeneration system P221
JunD, in mechanically stimulated bone regeneration system P221
kainate receptors, osteoclast resorption and P298
Klinefelter's syndrome, ibandronate therapy P545
Korea, histomorphometric analysis of iliac bone P31
Kostmann's congenital neutropenia, G-CSF treated P311
kyphoplasties, for fixation of vertebral fractures P532
kyphosis, thoracic, vertebral morphometry and P320
L-770874 OR69
lactation
BMD changes P26
bone mass and bone turnover markers after P354
bone mass in postmenopausal women and P510
lasofoxifene, in ovariectomized monkeys P594
left-right differences, QUS of os calcis P3
leptin
effects on bone strength OR73
mechanisms of action on bone P214
regulation of bone mass OR74
as skeletal growth factor OR55
leukemia inhibitory factor (LIF)
osteoprogenitor cell differentiation and P178
versus IL-6 and oncostatin M P273
lifestyle
radius fractures and P381
VDR genotype interactions P504
limb bud
Hox genes IN17
linkage analysis
osteoporosis OR10
Paget's disease of bone OR52
lipid profile, serum
and bone mass in healthy men P418
Ca supplements in postmenopausal women and P586
in hemodialysed postmenopausal women, raloxifene and P593
liver transplantation
bone changes in children after P101
fractures after P135
LLC-PK1 cells, nuclear targeting of PTHR-GFP constructs P186
Longitudinal Aging Study Amsterdam OR16
long-term potentiation (LTP), in bone OR72
losartan, skeletal effects P518
low frequency magnetic fields, in ovariectomized rats P533
lumbar spine
BMC distribution, age and gender differences P441
BMD
in anorexia nervosa P382
dietary effects in postmenopausal women P378
in females in Moscow P304
intraindividual coefficient of variation P324
in Japanese boys and girls P434
lasofoxifene and P594
lateral versus PA P332
menopausal age and BMI and P307
trabecular bone volume and P323
genetic factors in osteoporosis P129
histomorphometry
adults in Croatia P432
age and gender differences P340
lung cells, PHEX gene expression P65
lung function, in vertebral fractures P315
lung transplant candidates, bone loss P416
luteinizing hormone (LH), effects on bone P195
LY333334 see parathyroid hormone 1-34, recombinant human (rhPTH(1-34))
lycopene, antioxidant effects in osteoclasts P297
lymphocytes
osteoclastogenesis and P264
total count (TLC), and femoral BMD P375
see also T cells
lysosomal proteins, apical exocytosis by osteoclasts P282
macrophage colony-stimulating factor (M-CSF)
Flt3 ligand substitution P270
in infantile osteoclast-poor osteopetrosis P61
TRAP+ osteoclast-like cell formation P267
macrophage inflammatory protein (MIP)-1
alpha, osteoclastogenic effects OR47
in multiple myeloma OR45
macrophages
clodronate metabolism P292
phagocytosis and differentiation P269
in TNFalpha-induced osteoclastogenesis OR8
macrophage stimulating protein (MSP) receptor (RON), in giant cell tumor cells P279
magnesium (Mg)
homeostasis, sweat loss in horses and SY16
serum, and PTH levels in dialysis patients P122
urinary excretion in postmenopausal women P349
magnetic fields, low frequency, in ovariectomized rats P533
magnetic resonance imaging (MRI), tendon healing P142
magnetic resonance (MR) spectroscopy
in hypophosphatasia P111
in hypovitaminosis D myopathy P93
male mice
ER-beta knockout OR35
mechanism of androgen actions on bone OR38
malignant tumors, osteoporosis and P157
mammographic X-ray equipment, digital X-ray radiogrammetry on P336
mandibular bone
loss in animal model of male osteoporosis P656
loss in edentulous and dentate ovariectomized rats P525
in ovariectomized monkeys P522
structure in Down syndrome P125
MAP kinase pathway see mitogen activated protein (MAP) kinase pathway
Mapuche Indians
hip fractures P377
postmenopausal osteoporosis P386
Marfan syndrome, differential diagnostics P102
mass spectrometer, inductively coupled plasma (ICP-MS) P322
mast cells, in primary bone tumors P159
matrix metalloproteinases (MMP)
osteoprotegerin-mediated stimulation SC4
stimulation by hGH P260
zinc staining P46
matrix vesicles (MV), epiphyseal growth cartilage P13
MAZ, PTHR1 P2 promoter activity and P188
mdm-2, in osteoblast differentiation P232
measles virus nucleocapsid transcripts, in Paget's disease P112
meat intake, postmenopausal bone loss and P378
mechanical stress/strain
bone modeling unit (BMU)-coupling P43
collagen fiber orientation and P45
collagen mineralization P222
early response gene expression P221
heparin-binding growth-associated molecule and P227
induced bone formation OR62
osteoclast resorbing activity and P299
in ovariectomized rats P526
TGF-beta1 and osteopontin expression and P228
transmission to osteocytes P30
mechanical unloading
adipocyte gene expression and SC34
in p53 knockout mice P480
medical students, calcaneal ultrasonometry P481
megakaryocytes, in Mpl knockout mice OR58
melatonin
effects on fibroblastic cytokines P230
in orchidectomized rats P476
melorheostosis, bisphosphonate treatment P105
men
androgen receptor and ER alpha genotypes P127
blood pressure and fracture risk P475
coronary atherosclerosis, bone mass P411
CYP19 mutations P512
distal forearm fractures SC27
on glucocorticoids, risedronate for P548
hypogonadal, testosterone therapy P596
inflammatory bowel disease, bone mass in P498
lipid profile and bone mass P418
alendronate therapy P557
bias in bone densitometry referrals P612
calcitonin therapy P579
causes in patients with hip fractures P478
COL1A1 Sp1 polymorphism and P479
COL1A2 Msp1 polymorphism and P477
cyclical etidronate therapy P540
distal forearm fractures SC27
ibandronate therapy P615
mandibular bone loss in animal model P656
raloxifene in healthy middle-aged OR31
raloxifene response in elderly OR32
transsexual, ER gene polymorphism P133
vertebral fractures, sex steroids and bone turnover P513
see also elderly men
menadione, intestinal Ca absorption and P146
menarche, age at, BMD and P391
menin, in TGFbeta signaling OR51
menstruation, osteoporotic distal and proximal radius fractures and P381
metacarpals
digital X-ray radiogrammetry SC15, P335, P336, P337
equine third, response to exercise P44
metaphyseal bone defect, BMP-2 gene therapy P50
metastatic bone cancer see bone metastases
methotrexate, low dose P508
methylation, PTHrP gene in breast cancer cells P58
mevastatin, inhibition of bone resorption OR70
Mg see magnesium
micro-CT
osteoporosis of teeth P312
ovariectomized monkey mandible P522
in rat models of osteoporosis P519
microdamage
limb bones of cursorial animals P446
in proximal femur P22
micro-FE models, predicting radius failure load SC28
microgravity
effects on osteoblast-like cells P223
signaling pathways in response SC43
microtubule organizing centers, osteoclast P284
microtubules, in nuclear import of PTHrP P191
Middle East immigrants, osteomalacia in P466
midkine, in osteogenic differentiation P207
milk basic protein P538
milk and dairy products, Ca intake from, in Warsaw region P384
mineralization
bone, in Fra-1 overexpressing mice P205
bone matrix, role of BMP-2 P47
collagen, in distraction osteogenesis P222
electrical stimulation and P236
mitochondrial membrane potential, in bisphosphonate-induced apoptosis P290
mitogen activated protein (MAP) kinase pathway
in osteoblast differentiation P251
osteoprotegerin signaling SC4
pentoxifylline actions SC42
in response to mechanical environment SC43
in TGFbeta stimulation of PTHrP OR49
MK801, osteoblast differentiation and OR24
molting, crustacean, role of SERCAs and PMCAs SY1
monkeys
ovariectomized see ovariectomized monkeys
serum osteocalcin in dexamethasone-treated P459
monoclonal gammopathies of unknown significance (MGUS), bone turnover markers and cytokines P164
monocytes, formation of TRAP+ osteoclast-like cells P267
mononuclear cells, peripheral blood see peripheral blood mononuclear cells
Morquio--Brailsford syndrome P104
mortality, hip fracture P428
mother-daughter pairs, osteoporosis in P407
mother-of-pearl, water-soluble matrix extract SY2
Mpl knockout mice OR58
mucopolysaccharidosis type IV, body composition and BMD P104
mule deer, osteon densities in limb bones P446
multiple endocrine neoplasia type 1 (MEN1) OR51
multiple myeloma (MM)
bone turnover markers and cytokines P164
inhibition of bone disease by OPG OR48
mechanism of bone destruction OR45, OR47
pamidronate and interferon-alpha P150
Multiple Outcomes of Raloxifene Evaluation (MORE) trial OR64, P595, P617
muscle
cells, 1,25(OH)2D3 signaling P653
development at puberty, gender differences P21
mass, lean, after exercise in postmenopausal women P482
strength, exercise in premenopausal women and P484
myopathy, in hypovitaminosis D P93
myositis ossificans progressiva P99
nacre, water-soluble matrix extract SY2
nadroparin, skeletal effects P527
natriuretic peptides, osteoblast differentiation and P229
N-cadherin, regulation of expression SC8
NE10790 SC2
NE21650 SC1
neprilysin, in human lung and A549 cells P65
net endogenous noncarbonic acid production (NEAP) SC17
neurapraxia, in myositis ossificans progressiva P99
neuropathic pain, zoledronic acid therapy P553
neutropenia, Kostmann's congenital, G-CSF therapy P311
NF-kB
in bone metastasis of breast cancer OR46
nickel-titanium (NiTi), cytotoxicity testing P237
nicotine, effect on osteogenesis and vascularity P233
Nigeria, Ca treatment of rickets P95
NiTi, cytotoxicity testing P237
nitrate output, urinary, in eNOS and nNOS knockout mice P194
nitric oxide (NO) IN1
osteoblast differentiation and P229
raloxifene signaling P590
TRAP inhibition P296
nitric oxide synthase
endothelial (eNOS)
cytokine-mediated activation P231
in fractured femoral neck OR15
knockout mice P194
mevastatin actions and OR70
raloxifene and P590
neuronal (nNOS), knockout mice P194
NMDA receptors
in osteoblast differentiation OR24
osteoclast resorption and P298
non-NMDA receptors, osteoclast resorption and P298
Nordic Track exercise, in premenopausal women P484
norethindrone acetate, and ethinyl estradiol in postmenopausal women P598
nuclear magnetic resonance spectroscopy see magnetic resonance (MR) spectroscopy
nude rats, human breast cancer P149
nurse-led osteoporosis screening, in primary care P330
nutrition
bone mass in postmenopausal women and P473
femoral BMD and, in postmenopausal women P375
maternal, long bone mineralization and P387
in psychological disability P472
see also diet; protein nutrition
obesity
leptin as skeletal growth factor OR55
mechanism of low fracture rates OR73
surgery, effects on BMD P463
occupation, lifetime, and hip BMD in elderly Chinese men P374
ochronosis P97
oestradiol see estradiol
oestrogen see estrogen
olpadronate
purinergic Ca2+ signaling pathway modulation P252
retention in Paget's disease P118
oncogenic osteomalacia, hypophosphatemic P90, P94
oncostatin M, versus IL-6 and LIF P273
oophorectomized rats see ovariectomized rats
orchidectomized rats
mandibular bone loss P656
melatonin therapy P476
serum TRAP 5B P351
orchidectomy, in BERKO mice OR35
Oreochromis mossambicus, role of scales in Ca metabolism SY4
os calcis, ultrasound see quantitative ultrasound (QUS), calcaneus
Osf2/Cbfa1, mice overexpressing OR25
ossification
endochondral see endochondral ossification
heterotopic, in traumatic brain injury P85
posterior longitudinal ligament (OPLL) P14, P15, P16, P226
osteoarthritis
in biglycan-fibromodulin knockout mice OR54
BMP-2 and BMP receptor in cartilage P49
COL1A1 Sp1 polymorphism and P136
collagen type III P36
EIIIA segment of fibronectin P34
hand, and osteoporosis P415
IGF-I and IGFBP-3, exercise effects P483
IGFBP-5 P181
microdamage in proximal femur P22
osteomalacia presenting as P96
spine, determinants in postmenopausal women P499
temporomandibular joint, BPC-157 and P27
vitamin K analog levels P348
see also osteophytes
osteoblasts
1,25(OH)2D3 P176
1,25(OH)2D3-induced capacitative cation entry P253
adhesion to orthopedic alloys P244
adrenomedullin and adrenomedullin receptors P202
alendronate actions P250
androgen actions SC41
apoptosis see apoptosis, osteoblast
ATP-induced ODF (RANKL) expression P274
behavior on surface modified titanium P234
BMP expression P52
bone allograft matrix and P238
calcitonin-related peptides and P144
carnitine derivatives and P242
caveolin-1 P219
connexin43 and PTH response SC37
control of bone formation IN6
dentin sialophosphoprotein P206
differentiation
c-Src and PKC isoforms regulating SC10
daidzein and P599
DeltaFosB proteins and OR20
estradiol plus vitamin D and P200
FK506 and P204
heparan sulfate proteoglycan expression P37
IL-11-induced P249
intracellular cGMP and P229
LIF-mediated inhibition P178
microgravity and P223
MK801 actions OR24
p53 and mdm-2 and P232
pentoxifylline actions SC42
PPAR gamma pathway P259
proteasome inhibitor actions OR19
stress-activated protein kinases and P251
DNA microarrays P199
electrical stimulation P236
electromagnetic field stimulation P241
eNOS P231
ER-alpha and ER-beta actions and interactions P201
estrogen related receptor (ERRa) OR71
FGF-2 and FGF receptor regulation SC44
focal adhesions and mechanical strain P224
fracture healing stimulin (Jin Pu Ye) and P198
genes, discovery and analysis SC6
gene targeting OR57
glucocorticoid inactivation OR23
group C Sox proteins P210
in hospitalized elderly P501
hypophysectomized rats P180
in idiopathic hypercalciuria P74
IL-6 P171, P172, P174, P223, P238
long-term potentiation (LTP) OR72
microgravity effects P223
N-cadherin expression SC8
nicotine and P233
novel osteoclast-inhibiting molecule OR1
and novel porous hydroxyapatite P235
Osf2/Cbfa1 overexpressing OR25
osteoprotegerin expression and secretion P170
oxytocin-stimulated proliferation P245
PMCA, sodium-calcium exchanger and PTHrP receptor SY9
responses to mechanical environment SC9, SC43
VDR expression P649
zinc mapping P256
osteocalcin
in breast and prostate cancer cells P163
equine P220
immunolocalization using FITC labeling P35
release from bone matrix P261
serum
dexamethasone therapy and P459
in hospitalized elderly P501
serum undercarboxylated, in type II diabetic osteoporosis P376
osteochondrosis, Ca and P supplementation and P64
osteoclast differentiation factor (ODF) see RANK ligand
osteoclast inhibitory lectin (OCIL), murine OR1
osteoclasts
antioxidant effects of lycopene P297
apoptosis see apoptosis, osteoclast
in bone allograft failure P23
clodronate actions P291
differentiation (osteoclastogenesis)
androgen and estrogen actions SC3
in Camurati-Engelmann disease P287
in connexin43 deficiency OR5
in deer antlers OR60
estradiol and raloxifene effects P295
from PBMCs P264, P271, P278, P285
IL-12 and IL-18 and OR6
inflammatory cytokines and IN2
mCSF and P267
MIPalpha-induced OR47
novel osteoblast-derived molecule inhibiting OR1
P2X7 receptors and P294
phagocytosis and P269
in prosthesis loosening and arthritis P277
in rat periodontium P276
in rheumatoid arthritis SC30
TNFalpha and OR8
Flt3 substitution for M-CSF P270
fusion, P2X7 receptors and P294
Gap 27 and activity P289
glucocorticoid actions P272
human, formation and isolation P271, P278, P285
hydroxyapatite ceramic resorption P263
IL-1-mediated cytoskeletal regulation OR3
inflammatory cytokines and IN2
integrin avb3 peptidomimetics SC5
intracellular vesicle traffic P283
matrix transcytosis in bone-resorbing P282
mechanical strain effects P299
microtubule organizing centers P284
modulation of function IN3
movement, calcium-dependent potassium current and P300
MSP receptor/RON expression P279
NE10790 actions SC2
non-NMDA receptors P298
precursors, endothelium-mediated recruitment P286
recombinant VSV G-protein P288
RGD-insulin action P262
size and resorptive activity P280
osteocytes
focal adhesions in bone P30
monoclonal antibody against rat P218
xenogenic immunoglobulins to (Osteolin) P179
osteodystrophy
carbon tetrachloride-induced hepatic P635
renal see renal osteodystrophy
osteogenesis see bone formation
osteogenesis imperfecta
brittle mouse model P66
differential diagnostics P102
pamidronate therapy OR34
osteogenic precursor cells (osteoprogenitors)
developmental markers P216
dexamethasone and progesterone-dependent P258
PTHrP signaling P240
see also bone marrow stromal cells
osteogenic sarcoma cells see osteosarcoma cells
Osteolin, in bone healing P179
osteolytic bone destruction
in metastatic breast cancer IN12, P161
in multiple myeloma OR45, OR47, OR48
osteoclastogenic markers and P277
in unicameral bone cyst P100
wear debris mediated, femoral head implant P33
osteomalacia
in Asian patients P467
in fluoride and aluminium intoxication P91
hypophosphatemic oncogenic P90, P94
in Middle East immigrants P466
presenting as osteoarthritis P96
tumor-induced OR78
osteomyelitis, Osteolin and P179
osteon
density, limb bones of cursorial animals P446
osteopenia
alendronate for vertebral fracture prevention P575
diabetic
diabetic foot development and P402
inhibition by amylin P495
pathogenic aspects in IDDM P403
diagnosis in postmenopausal women P622
hip, in ochronosis P97
in Kostmann's congenital neutropenia P311
in peritoneal dialysis patients P88
physiological versus true P308
in postmenopausal women, effects of exercise P482
in primary biliary cirrhosis P543
osteopetrosis
corticosteroid therapy P98
in fluoride and aluminium intoxication P91
osteoclast-poor, RANKL and M-CSF therapy P61
osteophytes
expression of BMPs P39
role of BMP-2 and BMP receptor P49
osteopontin (OPN)
breast cancer metastasis and P153
mechanical strain and P228
urinary, estrogen therapy and P491
osteoporosis
in alcohol abuse P465
attitudes in two European regions P318
breast cancer and P511
case finding strategies P620
in cerebral palsy P572
COL1A1 Sp1 polymorphism and OR9, P128, P136
colchicine for P607
in congenital hip dysplasia P406
consanguineous family with P130
in Crohn's disease P71
cystatin C and P507
cytokines and osteoprotegerin ligand P175
diagnosis IN8
DXA machines compared P310
economic comparisons P629
QCT versus pQCT P331
ultrasound cut-off criteria P370
ultrasound versus DXA P359
see also bone mineral density
in elective arthroplasty patients P366
glucocorticoid-induced see glucocorticoid-induced osteoporosis
goat model P523
hand osteoarthritis and P415
HRT for prevention OR27
in hypertensive women P408
in hyperthyroidism, GH changes P412
Icelandic linkage study OR10
IGF-I and IGFBP-3, exercise effects P483
in Klinefelter's syndrome P545
in laying hens SY6
in malignant tumors P157
in men see men, osteoporosis
in mother-daughter pairs P407
in mucopolysaccharidosis type IV P104
ovariectomized rat model see ovariectomized rats
pancreatic elastase I stool content and P420
postmenopausal see postmenopausal osteoporosis
premenopausal P378
quality of life see quality of life, in osteoporosis
rat models compared P519
in rheumatoid arthritis SC30, P371
in rheumatological diseases P422
risk assessment
in Asian women P319
and bone densitometry P620
in fracture patients P364
in Japanese women P316
by peripheral bone mass P423
in postmenopausal women P622
in primary care P330
screening
educational program after P619
low-cost P314
nurse-led, in primary care P330
versus clinical risk factors P423
somatotropic and gonadotropic changes and OR17
teeth P312
TGF-beta1 genotype and P140
treatment
alendronate see alendronate, in osteoporosis
BMP-6 OR67
clinical trials IN9
cost in Ecuador P623
in Crohn's disease P563
electromagnetic field P534
etidronate SC20
home isometric resistive exercise P603
human PTH (1-34) P625
intravenous pamidronate P560
monitoring response P613
natural Brazilian dolomite P373
side effects and discontinuation rates OR28
urinary cAMP suppression test P492
vertebral trabecular bone changes P342
vitamin D and PTH relationship P584
vitamin K analog levels P348
in young people, genetic factors P129
see also fractures
osteoprotegerin (OPG)
in calcified atherosclerotic lesions P80
effects of age, 1,25(OH)2D3 and PTHrP P170
in glucocorticoid-induced osteoporosis P272
ligand (OPGL) see RANK ligand
myeloma bone disease and OR48
in osteoporosis P175
in prosthesis loosening and arthritis P277
regulation by IL-6, LIF and oncostatin M P273
serum, in cardiac transplant patients SC31
stimulation of metalloproteinase activities SC4
toxic effects in uremia P76
osteoradionecrosis, therapeutic ultrasound P243
osteosarcoma cells
mechanical strain effects P228
NiTi toxicity P237
TRAIL induced apoptosis OR50, P160
ovariectomized monkeys
lasofoxifene P594
micro-CT of mandible P522
rhPTH therapy P626
ovariectomized rats
alendronate and enzyme therapy P555
alfacalcidol
and alendronate P520
versus vitamin D P636
versus vitamin K2 P633
benzo[a]pyrene and resveratrol in estrogen-replete P528
bone loss in edentulous and dentate mandible P525
cerivastatin therapy P517
Chinese herbal preparation P606
copper deficiency P521
dietary P intake P496
effects of old antler P239
high dietary Ca and mechanical strain P526
low frequency magnetic field therapy P533
microstructural changes P519
osteoprogenitors P258
with renal failure, calcitriol therapy P124
oviduct motility, PTH polyhormone actions SY13
oxidative stress
in copper deficiency P521
intestinal Ca absorption and P146
oxytocin, osteoblast proliferation and P245
oyster, giant (Pinctada maxima), water-soluble matrix extract of nacre SY2
P2 receptors, upregulation of ODF (RANKL) expression P274
P2X7 receptors, in osteoclast formation P294
p53
knockout mice, mechanical unloading P480
in osteoblast differentiation P232
Paget's disease of bone (PDB)
IGFBP-5 P181
measles virus nucleocapsid transcripts P112
olpadronate retention P118
sex differences P119
temporal decline in severity P114, P115
tiludronate treatment P116
type I and type II collagen metabolism P117
pain
chronic inflammatory and neuropathic, zoledronic acid P553
electroalgometry P313
see also analgesic effects
pamidronate
in breast cancer P151
in cerebral palsy P572
in Crohn's disease P563
in difficult osteoporosis P560
home therapy P544
in multiple myeloma P150
in osteogenesis imperfecta OR34
in postmenopausal osteoporosis P542, P567
Pamukkale Osteoporosis Study, Turkey P400
pancreatic elastase I stool content, osteoporosis risk and P420
pancreatic insufficiency, chronic P497
parathyroid adenoma, localization methods P60
parathyroidectomy
BMD changes after P57
parathyroid adenoma localization P60
parathyroid glands, ex vivo functionality and viability P193
parathyroid hormone (PTH)
biphasic anabolic and catabolic effects OR41
in Ca and vitamin D supplementation P642
in Ca supplementation P588
catecholamines in endurance exercise and P183
in chronic metabolic acidosis P184
connexin43/gap junctions and SC37
in dialysis patients, serum Mg and P122
in equine enterocolitis and hypocalcemia SY15
feline SY11
inhibition by aluminium P192
inhibition by retinoic acid P189
oviduct motility and SY13
regulation of BMP expression P52
resistance in uremia P76
seasonal variations P464
signaling in intestinal cells P185
in streptozotocin-diabetic rats P190
versus statins OR43
in vitamin D deficiency P585, P644
vitamin D relationship in osteoporosis P584
parathyroid hormone 1-34, recombinant human (rhPTH(1-34))
cortical bone strength indices after OR66
digital X-ray radiogrammetry for assessing response SC33
nonvertebral fracture risk reduction SC12
in osteoporosis, effects on trabecular bone P625
in ovariectomized monkeys P626
plus oral estrogen OR30
in streptozotocin-induced diabetic rats P624
vertebral fracture prevention OR29
parathyroid hormone/parathyroid hormone-related protein (PTH/PTHrP) receptor (PTH1R)
in hematopoietic marrow formation OR56
ligand-mediated regulation OR75
MAZ and P2 promoter activity P188
nuclear targeting in LLC-PK1 cells P186
in osteoblasts of young and aged rats SY9
in spontaneously hypertensive rats SC36, P187
parathyroid hormone-related protein (PTHrP)
alendronate actions P250
carboxy-terminal (osteostatin) region OR76
DNA methylation P58
feline head and neck squamous cell carcinoma cells P55
IL-6 expression and P172
in metastatic bone destruction IN12, P161
nuclear import P191
osteoprotegerin and P170
oviduct motility and SY13
P3 promoter and ETS-1 site P59
prevention of renal ischemia OR42
signaling in osteogenic cells P240
in spontaneously hypertensive rat SC36
Parkinson disease, BMD P414
peak bone mass (PBM)
central versus peripheral BMD P306
ERalpha genotype and P141
in Venezuelan population P309
pediatric patients see children
pelvic BMD, in Henan province P328
pentadecapeptide BPC-157 P27, P28
pentoxifylline, molecular mechanisms SC42
perimenopausal women
alcohol intake and bone loss SC24
asthma and fracture risk P409
frequency of densitometry P302
periodontal ligament, cell lines derived from P217
periodontium, ODF (RANKL) and osteoclast development P276
periosteal cell line, human (hPOB-tert) P246
peripheral arterial occlusive disease P494
peripheral blood mononuclear cells (PBMC)
in Camurati-Engelmann disease P287
caveolin-1 P219
cytokines in pregnancy and puerperium SY10
endothelium-mediated recruitment P286
estradiol and raloxifene effects P295
human osteoclasts from P278, P285
osteoclast-forming potential P264
RANKL induction of osteoclastogenesis P271
peripheral quantitative computed tomography (pQCT)
calcitonin therapy and P580, P581
in distraction osteogenesis P2
gender differences in distal radius P431
prediction of radius failure load SC28
rhPTH(1-34) therapy and OR66
versus QCT in osteoporosis P331
peritoneal dialysis (CAPD)
diagnosis of "true" osteopenia P88
skeletal changes P73
peroxisome proliferator-activated receptor (PPAR) gamma P259
phagocytosis, in osteoclast-macrophage lineage choice P269
phalanges, finger, QUS in pediatric patients P367
phantoms, DEXA, for infants P438
phenytoin plus alfacalcidol, vitamin K analogs and P450
PHEX gene
expression in bone P214
in human lung and A549 cells P65
Phlogenzym and alendronate, in ovariectomized rats P555
phorbol ester, N-cadherin expression and SC8
phosphate (Pi) transport
in human lung and A549 cells P65
in oncogenic osteomalacia P94
regulation by extracellular Pi P213
stimulation by BMP-2 P47
phosphate (Pi) transporter, in osteoblasts P213
phosphorus (P)
dietary
hypothalamic-pituitary mRNA expression and P471
trabecular bone mass and strength and P496
supplementation in young dogs P64
urinary excretion
in equine enterocolitis and hypocalcemia SY15
in postmenopausal women P349
physical activity
bone mass at 36 years and P435
see also exercise
physical education students, calcaneal ultrasonometry P481
physical impairment, multiple nonspine fractures and P427
phytoestrogens, effects on osteoblasts P599
piglets, bone strength prediction P439
pigs
bone ingrowth into implants P18
daidzein and osteoblast differentiation P599
degenerative joint disease P106
glucocorticoid-treated P455
ultrasound transmission velocity of osseous implantation site P489
vegetarian versus fish-meal diet SY17
Pinctada maxima, water-soluble matrix extract from nacre SY2
pituitary diseases, fracture risk P399
pituitary-gonadal axis, raloxifene therapy and male OR31
plasma membrane Ca-ATPase (PMCA)
in crustacean molting SY1
in osteoblasts of young and aged rat long bone SY9
pleiotrophin, in osteogenic differentiation P207
PMCA see plasma membrane Ca-ATPase
Poland, Ca intake from milk and dairy products P384
polyethylene, IL-6 expression and P171
polyethyleneimine, for porous hydroxyapatite formation P235
polymerase chain reaction (PCR)
differential display, LIF P178
reverse transcription (RT-PCR), IGF-I quantitation P182
species-specific, metastatic cells P152
poly(vinylalcohol) gel matrix, fluoride and apatite formation P529
positron emission tomography (PET), cartilagenous bone tumors P158
posterior longitudinal ligament, ossification (OPLL) P14, P15, P16, P226
postmenopausal osteoporosis
alendronate therapy see alendronate, in postmenopausal osteoporosis
alfacalcidol for prevention P637
bone resorption markers P608
breast cancer and P511
calcitonin therapy see calcitonin, in postmenopausal osteoporosis
COL1A1 polymorphism and P128
genetic factors in Russia P410
health related quality of life P628
HRT, bisphosphonate, calcitonin, vitamin D and vitamin K compared P552
HRT and pamidronate P567
low-cost screening P314
in Mapuche Indians P386
pamidronate therapy P542
raloxifene therapy OR64, P595, P617
rat model see ovariectomized rats
rhPTH(1-34) therapy SC12, OR29, OR30, SC33
urinary B, Ca, Mg and P excretion P349
zoledronic acid by annual injection OR80
postmenopausal women
alcohol intake and bone loss SC24
alendronate after successful cyclical etidronate P549
apolipoprotein E genotype P139
bone turnover markers P344, P345, P346
calcitonin receptor Alu I polymorphism P143
Ca supplements, serum lipid effects P586
COL1A1 polymorphism and P128, P132
diagnosis of low bone mass P622
dietary factors in spinal osteoarthritis P499
diet and spinal bone loss P378
ERalpha genotypes P141
ethinyl estradiol and norethindrone acetate P598
exercise in osteopenic P482
FC1271A versus raloxifene P601
forearm fracture prevention OR27
fracture risk factors P405
frequency of densitometry P302
hemodialysed, raloxifene therapy P593
hormone replacement therapy see hormone replacement therapy
influence of pregnancy and lactation on bone mass P510
nurse-led screening in primary care P330
nutritional factors affecting bone mass P473
Pamukkale Osteoporosis Study, Turkey P400
pravastatin therapy P530
protein intake and bone loss P587
protein nutrition and femoral BMD P375
QUS P360
after stopping training P488
and DEXA P365
and exercise P487
raloxifene therapy P600
rheumatoid arthritis, etidronate, vitamin K and vitamin D P571
risedronate therapy see risedronate, in postmenopausal women
statins and bone loss P535
Tai Chi exercise P604
telopeptide derived degradation products of collagen type I P343
TGF-beta1 polymorphisms P137
total hip versus femoral neck BMD P327
urinary B, Ca, Mg and P excretion P349
VDR Fok I polymorphism and BMD P650
vitamin D-deficient, Ca and vitamin D therapy P585
see also elderly women
postpartum period, cytokines mediating bone loss SY10
post-traumatic syndrome, foot algo-dystrophic P67
posture, and BMD in elderly women P424
pravastatin, in postmenopausal women P530
pre-adipocytes, bone-specific gene induction by statins P208
prednisolone, in Gottingen minipigs P455
pregnancy
adolescent, Ca supplementation P436
BMD changes P26
bone mass and bone turnover markers after P354
bone mass in postmenopausal women and P510
bone turnover markers and 1,25(OH)2D3 P389
cytokines mediating bone loss SY10
premature menopause
BMD and biochemical markers P516
BMD variation according to type P515
premenopausal women
BMD and BMC, in vegans and omnivores P388
congenital hip dysplasia P406
osteoporosis P378
QUS after stopping training P488
Step Master and Nordic Track exercise P484
preproparathyroid hormone, feline SY11
preterm infants, bone mass and bone turnover markers in mothers P354
primary biliary cirrhosis, alendronate versus etidronate P543
primary care, nurse-led osteoporosis screening P330
procollagen type I
bone allograft and P238
N-terminal propeptide (PINP)
pravastatin therapy and P530
puberty, aging and gender effects P505
raloxifene therapy and P617
propeptides, in renal osteodystrophy P86
progesterone-dependent osteoprogenitors, in ovariectomized rats P258
Pronosco X-posure System P335, P336, P337
prostaglandin E2, effects of melatonin P230
prostaglandins, FGF-2 and FGF receptor regulation SC44
prostate cancer
androgen ablation therapy P121
bone sialoprotein expression P163
osteoblastic metastases P120
prostate tissue, induction of bone formation P120
prosthetic implants see implants
proteasome inhibitors OR19
proteinases, stimulation by hGH P260
protein kinase C (PKC)
bisphosphonate actions P293
calcitonin-related peptides and P144
isoforms, in osteoblast differentiation SC10
PTHrP signaling P240
regulation of N-cadherin SC8
protein kinase A (PKA), pentoxifylline signaling and SC42
protein kinase B (PKB/AKT), mechanical strain and SC9
protein nutrition
femoral BMD and, in postmenopausal women P375
osteoporosis and OR17
postmenopausal bone loss and P587
pseudo vitamin D deficiency rickets, animal model P648
psoriasis, methotrexate therapy P508
psychological disability, energy and nutrient intake P472
PTH see parathyroid hormone
puberty
bone turnover markers and P505
gender differences in bone and muscle development P21
puerperium, cytokines mediating bone loss SY10
pulmonary disease, end stage P416
purinergic Ca2+ signaling pathway, olpadronate/IG-9402 and P252
pyridinoline, urinary, for monitoring treatment response P613
quality of life, in osteoporosis
calcitonin therapy and & nbsp; P631
measurement using modified SF12 P630
treatment of postmenopausal women and P628
quantitative computed tomography (QCT)
in normal pre- and post-pubertal females P433
peripheral see peripheral quantitative computed tomography
versus pQCT in osteoporosis P331
quantitative trait loci (QTLs)
BMD OR61
vertebral trabecular bone OR12
quantitative transmission disequilibrium test (qTDT) SC29
quantitative ultrasound (QUS)
ankle fractures and P426
in asthmatic children P453, P454
calcaneus (os calcis)
in athletic and medical students P481
in children and adolescents P3, P4
comparison between two devices P368
in fracture patients P364
handy CM100 device P363
pregnancy and lactation and P510
in rheumatoid arthritis P371
VDR genotypes and P602
versus digital X-ray radiogrammetry P334
versus DXA P359
in vertebral and hip fractures P360
women in rural mountainous Honduras P362
in chicken tibia model P361
exercise levels and P487
finger phalanges, European pediatric reference data P367
in hyperthyroidism P369
normal values in healthy Caucasian boys P430
osteoporosis cut-off values P370
versus DEXA in postmenopausal women P365
in women with fractures and normal DEXA BMD P372
in women with low fracture risk and low BMD P339
quinapril, BMD and P531
QUS see quantitative ultrasound
Rab proteins
inhibition of prenylation SC2
in osteoclast function IN3, OR4
radiogrammetry
clavicle, to predict hip BMD P314
digital X-ray see digital X-ray radiogrammetry
radiotherapy
-induced osteonecrosis, ultrasound therapy P243
in myositis ossificans progressiva P99
radius
distal, gender differences P431
fractures, lifestyle, anthropometric and menstrual factors P381
prediction of failure load SC28
see also forearm, distal
raloxifene
genomic effects in osteoblasts P199
in healthy middle-aged men OR31
in hemodialysed postmenopausal women P593
IL-6 and P174
nitric oxide signaling P590
osteoclast differentiation and P295
osteoporotic fracture prevention IN9
in postmenopausal osteoporosis OR64, P595, P617
side effects and discontinuation rates OR28
smoking and efficacy P595
urinary Ca loss and P600
versus FC1271A P601
vertebral fracture prevention OR64
RAMP (receptor-activity-modifying proteins) OR44
RANK
in prosthesis loosening and arthritis P277
regulation by IL-6, LIF and oncostatin M P273
RANK ligand (RANKL, TRANCE, OPGL, ODF)
in bone allograft failure P23
in calcified atherosclerotic lesions P80
in cancer-induced osteolysis P161
in connexin43 deficiency OR5
control of bone resorption P265
estrogen and androgen actions SC3
in glucocorticoid-induced osteoporosis P272
in idiopathic hypercalciuria P74
in infantile osteoclast-poor osteopetrosis P61
in osteoclast differentiation and function IN2
osteoclast inhibitory lectin and OR1
osteoclast-macrophage lineage destiny and P269
in osteoporosis P175
P2 receptor stimulation and P274
in prosthesis loosening and arthritis P277
PTH-mediated activation OR41
in rat periodontium P276
regulation by IL-6, LIF and oncostatin M P273
in TNFalpha-induced osteoclastogenesis OR8
ras/MAPK pathway
osteoprotegerin signaling SC4
PTHrP signaling P240
RAW 264 macrophages, clodronate metabolism P292
reactive oxygen species (ROS), inhibition by lycopene P297
receptor activator of NFkappaB see RANK
receptor-activity-modifying proteins (RAMP) OR44
rehabilitation program, in elderly women P605
renal failure
Ca supplementation P148
chronic
with estrogen deprivation P124
PTH inhibition by aluminium P192
ischemic, prevention OR42
renal function, cystatin C and P507
renal osteodystrophy
1-alpha(OH)D3 therapy P77
in peritoneal dialysis patients P73
role of osteoprotegerin P76
serum propeptides of type I procollagen P86
renal transplantation
bone turnover markers P506
IL-6 involvement in bone remodeling P87
pathogenesis of osteodystrophy P75
renal vascular resistance (RVR), PTHrP system and SC36
renin, plasma activity, PTH1 receptor and P187
reproduction, mammalian, skeletal growth, modeling, remodeling and metabolism SY14
residronate, osteoporotic fracture prevention IN9
resveratrol, in estrogen replete ovariectomized rats P528
retinoic acid (RA)
in deer antlers OR60
PTH inhibition P189
retinoic acid receptors (RAR), in deer antlers OR60
retinoid X receptors (RXR), VDR interaction OR39
retroviral vector, BMP4 transduction OR21
reverse transcription-polymerase chain reaction (RT-PCR), IGF-I quantitation P182
RGD-insulin, mechanism of anti-bone resorption P262
rheumatoid arthritis (RA)
alfacalcidol therapy P639
EIIIA segment of fibronectin P34
etidronate, vitamin K and vitamin D P571
forearm BMD P490
infliximab therapy P353
osteoclastogenic markers P277
pathogenesis of osteoporosis SC30
QUS in osteoporosis P371
role of IL-17 OR7
rheumatological diseases, osteoporosis risk P422
ribavirin, in chronic hepatitis C P72
rickets
Ca treatment in Nigeria P95
in hereditary tyrosinemia type 1 (HT-1) P84
hypophosphatemic, Ca supplementation and P64
pseudo vitamin D deficiency, animal model P648
risedronate
gastric ulcers and P546
in glucocorticoid-treated men P548
hip fracture prevention P547
phosphonocarboxylate analog SC2
in postmenopausal women
fracture prevention P570, P577
GI-intolerant to alendronate P569
on glucocorticoids P568
vertebral fracture prevention P558, P559, P568, P570
RON (macrophage stimulating protein (MSP) receptor), in giant cell tumor cells P279
Ros 17/2.8 osteoblast-like cells, capacitative cation entry P253
Ros-17 osteosarcoma cells, NiTi toxicity P237
rotator cuff tendons, calcification P8
Runx2, FGF2 and FGFR-2 signaling P211
Russia, genetic factors in osteoporosis P410
Saethre-Chotzen syndrome SC11
Saos-2 cells
heparin-binding growth factors P207
oxytocin-stimulated proliferation P245
scales, fish, role in Ca metabolism SY4
scanning electron microscopy (SEM), cells in contact with bone P247
sciatic neurectomy, microstructural changes P519
SCID/beige mice, humoral hypercalcemia of malignancy P54
sclerosteosis, SOST mutations OR77
screening, osteoporosis see osteoporosis, screening
seasonal variations
25OHD and PTH P464
in bone loss, prevention SC18
bone turnover markers P356
vitamin D levels in Florida outpatients P645
selective estrogen receptor modulators (SERMs)
FC1271A versus raloxifene P601
molecular pharmacology IN11
regulation of IGF-I gene SC40
see also lasofoxifene; raloxifene; tamoxifen
SERCAs, in crustacean molting SY1
sesamoid bones, ectopic, in biglycan-fibromodulin knockout mice OR54
99mTc-sestamibi subtraction scintigraphy P60
sex differences see gender differences
sex steroids
in men with vertebral fractures P513
see also androgens; estrogen
SF12, modified, in osteoporosis P630
sheep, maternal nutrition and long bone mineralization in fetal P387
shoulder, calcified tendinitis P8
signal transducer and activator of transcription 1 (STAT1), activation by FGFR3 gene mutations OR53
sit-to-stand test, in fracture prediction SC16
skin
impedance, electroalgometry P313
irritation by nitrogen-bisphosphonates SC22
Smad3, menin interactions OR51
smoking, cigarette
and BMD in postmenopausal women on HRT P398
and bone turnover, during HRT P591
raloxifene efficacy and P595
alpha-smooth muscle actin, in fibrous dysplasia P108
socioeconomic deprivation
fracture risk in older people and P401
referral for bone densitometry and P303
sodium-calcium exchanger
in chick enterocytes P651
in osteoblasts of young and aged rat long bone SY9
sodium fluoride, osteoblast apoptosis and P197
SOST mutations, in sclerosteosis OR77
South Africa
X-linked hypophosphatemia P92
ethnic differences in bone mass P126
Sox proteins, group C, in osteoblasts P210
soybeans, fermented, skeletal effects P589
Spain
bone health of women P390
digital X-ray radiogrammetry P334
spinal ligament cells, mechanical stress P16, P226
spine
diet and postmenopausal bone loss P378
lumbar see lumbar spine
osteoarthritis, determinants in postmenopausal women P499
spondylosis deformans, index of P324
Spongiosa Metal Surface total hip arthroplasty P103
spontaneously hypertensive rat (SHR)
PTH1 receptor and plasma renin activity P187
PTHrP system in renal vessels SC36
sports school students, calcaneal ultrasonometry P481
squamous carcinoma cells, regulation of PTHrP P56
Src
1,25(OH)2D3 signaling in muscle cells P653
Cbl interaction OR2
in IL-1-mediated osteoclast regulation OR3
in osteoblast differentiation SC10
in response to mechanical environment SC43
STAT1, activation by FGFR3 gene mutations OR53
statins
bone formation mediated by OR22
bone loss in postmenopausal women and P535
bone mass effects OR13
fracture prevention OR13, OR79
inducing bone-specific genes in preadipocytes P208
in ovariectomized rats P517
versus low-dose PTH OR43
Step Master exercise, in premenopausal women P484
streptozotocin-diabetic rats
amylin inhibits osteopenia P495
anabolic effects of h-PTH (1-34) P624
calcitriol therapy P655
PTH secretion P190
stress
mechanical see mechanical stress/strain
skeletal growth in inbred mice and P62
traumatic, skeletal growth in inbred mice and P62
stress-activated protein kinases, in osteoblast differentiation P251
STRO-1, osteogenic precursor cells P216
surgery for obesity, effects on BMD P463
sweat loss, equine Ca and Mg homeostasis and SY16
Synchrotron radiation microtomography, in etidronate-treated osteoporosis SC20
systemic lupus erythematosus, BMD in P444
tacrolimus see FK506
Tai Chi exercise, in postmenopausal women P604
tamoxifen, IL-6 and P174
tantalum biomaterial, for bone replacement P32
tartrate-resistant acid phosphatase (TRAP)
inhibition by NO P296
serum 5B, as bone resorption marker P350, P351
T cells
IL-17-mediated actions OR7
inhibitor of osteoclast formation OR6
TNFalpha production in estrogen deficiency OR37
99mTc-sestamibi subtraction scintigraphy P60
teleost fish, osteocalcin P9, P10
temporomandibular joint osteoarthrosis, BPC-157 and P27
tendon healing
BPC-157 and P28
effect of calcitonin P142
testosterone, in hypogonadal men P596
TGF-beta see transforming growth factor beta
thanatophoric dysplasia OR53
thoracic kyphosis, vertebral morphometry and P320
thrombin peptide, synthetic, in femoral fracture healing P25
thrombopoietin receptor (c-Mpl), knockout mice OR58
tibial fractures, traumatic brain injury and P85
tilapia, role of scales in Ca metabolism SY4
tiludronate, in Paget's disease P116
titan implants, bone ingrowth P18
titanium
alloys, osteoblast adhesion P244
surface modified, osteoblast behavior P234
TNF-alpha see tumor necrosis factor-alpha
tooth
morphogenesis, genetic basis IN14
osteoporosis, micro-CT measurement P312
TP508, in femoral fracture healing P25
trabecular bone
cerivastatin and P517
density and architecture OR12
fractal analysis P448
fractal dimension P452
HRT in rats and mice and P447
mass and strength, dietary P and P496
in mechanically unloaded p53 knockout mice P480
mechanism of androgen actions OR38
in osteoporosis P342
volume, lumbar spine BMD and P323
Traf6/c-Src complex, in IL-1-mediated osteoclast regulation OR3
TRAIL-induced apoptosis OR50, P160
TRANCE see RANK ligand
transforming growth factor beta (TGF-beta)
feline head and neck squamous cell carcinoma cells P55
menin interactions OR51
osteoclastogenesis and P264
transforming growth factor beta1 (TGF-beta1)
gene, in Camurati-Engelmann disease OR59
mechanical strain effects P228
transforming growth factor beta2 (TGF-beta2), adipocyte gene expression and SC34
transmission disequilibrium of quantitative traits (qTDT) SC29
transsexual men, ER gene polymorphism P133
TRAPs (DRIPs) IN16
traumatic brain injury, heterotopic ossification P85
trisomy 21, mandibular bone structure P125
troglitazone P20
TRPC3-like protein, in capacitative cation entry P253
tumor-induced osteomalacia OR78
tumor necrosis factor-alpha (TNFalpha)
antibody, in rheumatoid arthritis P353
in bone loss of pregnancy and puerperium SY10
in estrogen deficiency OR37
IL-17 interaction OR7
induction of osteoclastogenesis OR8
menstrual cycle phase and P268
osteoclast actions IN2
osteoclast-macrophage lineage destiny and P269
in osteoporosis P175
in renal osteodystrophy and P77
tumor necrosis factor-related activation-induced cytokine (TRANCE) see RANK ligand
tumors
BMP and BMPR expression P51
hypophosphatemic oncogenic osteomalacia P90, P94
malignant, osteoporosis and P157
Turkey, Pamukkale Osteoporosis Study P400
twin study, falls OR11
Twist protein, fgfr2 interaction SC11
tyrosinemia, type 1 hereditary P84
tyrosine phosphatases, in glucocorticoid osteoporosis P254
ulcerative colitis
bone histomorphometry P81
bone mass in men P498
ultrasound
quantitative see quantitative ultrasound
therapeutic, in osteoradionecrosis P243
transmission velocity, osseous implantation site P489
UMR-106 cells, mechanical strain P228
upper gastrointestinal (GI) symptoms
alendronate rechallenge SC21
evidence for effects of bisphosphonates P564
risedronate after alendronate discontinuation for P569
uremia
toxic role of osteoprotegerin P76
see also renal failure
urinary cAMP suppression test, in osteoporosis P492
urine samples, 2-hour fasting versus 24-hour, for bone resorption markers P345
van Buchem disease OR77
vascular endothelial growth factor (VEGF)
effect of TP508 P25
fracture healing and age effects P177
vascularity, effect of nicotine P233
vascular smooth muscle (VSM) cells, PTHrP actions OR76
vegans, premenopausal BMD and BMC P388
vegetarian diet
bone resorption and P524
versus fish-meal, in pigs SY17
Venezuela, peak bone mass P309
vertebrae
deformities in ankylosing spondylitis P82
morphometry, thoracic kyphosis and P320
trabecular bone
changes in osteoporosis P342
density and architecture OR12
vertebral fractures
back pain and disability before and after P394
in cardiac transplant patients SC31
in Chinese women, alendronate therapy P566
COL1A1 polymorphism and P128
diagnostic algorithm P317
kyphoplasties for fixation P532
in men, sex steroids and bone turnover P513
in osteopenia, alendronate for prevention P575
PA versus lateral lumbar spine BMD P332
proximal femur BMD and P326
QUS of os calcis P360
raloxifene for prevention OR64, P617
reduced lung function P315
in rheumatoid arthritis P371
rhPTH(1-34) therapy OR29
risedronate for prevention P558, P559, P568, P570
risk factors OR63
vertebrates
Hox genes in limb evolution IN17
vesicles
intracellular, in living osteoclasts P283
matrix (MV), epiphyseal growth cartilage P13
membrane, calcification P5
vesicular stomatitis virus (VSV), recombinant glycoprotein P288
vitamin D
deficiency
biochemical markers and bone histology P467
biochemical measures and BMD P470
BMD and P582
Ca and vitamin D therapy P469, P585
in elderly hospitalized patients P643
in elderly, PTH status P644
fracture risk and OR16
myopathy P93
in peripheral arterial occlusive disease P494
presenting as osteoarthritis P96
dietary requirements SY19
and estradiol, osteoblast differentiation and P200
in hip fracture prevention OR33
importance to bone throughout life SY18
metabolism
C-3 epimerization pathway P647
bone cell regulation P646
negative regulation of bone formation OR40
PTH relationship in osteoporosis P584
seasonal variation, in Florida outpatients P645
status
in ankylosing spondylitis P503
in elderly women with hip fractures P385
pancreatic elastase I stool content and P420
supplementation
in Crohn's disease P563
GP's knowledge about P640
osteoporotic fracture healing and P641
in postmenopausal osteoporosis P552
PTH response P642
in rheumatoid arthritis P571
timing, dose and choice SY21
versus treatment SY20
in vitamin D deficiency P469, P585
winter time SC18
supplemented yoghurts, for elderly P462
versus alfacalcidol P636
vitamin A and Ca response P652
see also alfacalcidol; 1,25-dihydroxyvitamin D3; 25-hydroxy vitamin D
vitamin D receptor (VDR) IN10
DRIP coactivator complex IN16
genotypes
BMD in Czech postmenopausal women and P650
fractures in liver transplant patients and P135
lifestyle factor interactions P504
osteoporosis in postmenopausal women and P410
and QUS indices in Japanese women P602
in human osteoblasts P649
knockout (VDRKO) bone OR40
shuttling OR39
in TNFalpha promoter repression P654
vitamin A, Ca response to vitamin D and P652
vitamin K (and analogs)
K2, versus alfacalcidol P633
in osteoporosis and osteoarthritis P348
phenytoin and alfacalcidol and P450
in postmenopausal osteoporosis P552
in rheumatoid arthritis P571
in type II diabetic osteoporosis P376
zonisamide and bone levels P634
vitronectin receptor (VnR), regulation by Src/ Cbl OR2
winter, cholecalciferol and Ca supplements SC18
women
bone health in Spanish P390
hypertensive, osteoporosis in P408
see also elderly women; perimenopausal women; postmenopausal women; premenopausal women
wrist fractures see forearm fractures, distal
X-linked hypophosphatemia P65, P92, P215
YM175, in type 2 collagen-induced arthritis P24
yoghurts, calcium/vitamin D-supplemented P462
young adults
BMD in Croatia P301
Ca intake and physical activity P435
COL1A1 Sp1 polymorphism and BMD P138
genetic factors in osteoporosis P129
zinc
anabolic effects in growing rats P41
mapping in osteoblasts and bone matrix P256
staining of MMPs and endonucleases P46
zoledronic acid
in chronic inflammatory and neuropathic pain P553
in postmenopausal osteoporosis OR80
zonisamide, vitamin K levels in growing rats and P634